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Both smoking and virus infection are risk factors for bacterial infections of the lower
respiratory tract. Serious secondary bacterial disease can occur following illness due to
respiratory viruses, and viral infections have also been suggested to be predisposing
factors for bacterial meningitis.
Previous studies found enhanced binding of pathogenic bacteria to cells infected with
Respiratory Syncytial Virus (RSV) which is an important cause of infection in infants,
young children and the elderly. While smoking is usually thought of as a risk factor for
viral infection, this study was designed to examine separately the effects of these two
factors on bacterial binding. The objectives of the study were: (1) to determine if there
is a similar pattern of enhanced binding of Neisseria meningitidis, Haemophilus
influenzae type b, Streptococcus pneumoniae, Staphylococcus aureus, and Bordetella
pertussis to RSV subgroup B infected cells as observed with RSV subgroup A infection;
(2) to determine if there is increased binding of other species of bacteria associated with
meningitis and those associated with secondary respiratory infections or exacerbation of
chronic bronchitis to RSV infected cells; (3) to determine if there was a similar pattern
of increased bacterial binding to influenza virus infected cells; (4) to determine if as
with RSV infected cells there was an increase in expression of native cell surface
antigens which can act as receptors for bacteria; (5) to determine if there is enhanced
binding of bacteria associated with meningitis or respiratory disease to cells of smokers;
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(6) to assess cells of smokers and non-smokers for differences in level of expression of
molecules proposed to act as bacterial receptors.
With the exception of an antibiotic-sensitive strain of Moraxella catarrhalis (MC2)
infection of an epithelial cell line (HEp-2) with RSV (subgroups A or B) enhanced
binding of all bacterial strains tested. Compared with the antibiotic-resistant strain,
MC2 and other antibiotic-sensitive isolates of M. catarrhalis were found to express
differences in outer membrane proteins, sensitive to complement-mediated killing.
With human monocytes or the THP-1 monocyte cell line, phagocytosis or intracellular
survival studies showed no differences between the two isolates ofM. catarrhalis.
Cells infected with human influenza A virus showed increased adherence of each of the
species tested, including the antibiotic-sensitive isolates of M. catarrhalis. Compared
with uninfected cells, influenza virus infected HEp-2 cells showed significantly
increased binding of monoclonal antibodies for the cell surface antigens CD 14 and
CD 18 that appeared to act as receptors for Gram-negative species tested. Pre-treatment
of HEp-2 cells with neuraminidase showed increased bacterial binding compared with
untreated HEp-2 cells, but the increase was less than that observed for influenza infected
cells.
Buccal epithelial cells from smokers bound more of each of the bacterial species tested,
but there were no differences between cells from smokers compared with non-smokers
in expression of blood group antigens, fibrinogen or fibronectin. Treatment of cells
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with an extract of cigarette smoke enhanced binding. Although the extract contained
material cross reactive with the H type 2 blood group antigen which acts as a receptor
for some strains, this could not completely explain the enhanced binding.
The results suggest that while smoking is a predisposing factor for viral infection, it can
independently enhance bacterial binding of strains associated with meningitis or
respiratory infection on its own.
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1.1 Bacterial infection of the respiratory tract
Two environmental factors, viral infection and exposure to cigarette smoke, have been
associated with susceptibility to bacterial infection of the respiratory tract. It has been
reported that both virus infection and active smoking increase the levels of bacterial
colonisation (Musher and Fainstein, 1981). The importance of colonisation of mucosal
surfaces as the first step in development of bacterial infection has been recognised for
many years. Most of the early work concentrated on the bacterial components involved
in binding to the host cell, and it became clear that density of colonisation reflected in
numbers of bacteria attached to epithelial cell surfaces was an important factor in
pathogenesis (Table 1.1) (Beachey, 1981). More recently, host factors that could affect
colonisation have been explored. Many of the clues to these factors have come from
epidemiological studies in which genetic, developmental and environmental factors
associated with susceptibility to bacterial diseases have been identified (Haneberg et al.,
1983; Pershagen, 1986; Stuart et al., 1988; Blackwell, 1989; Blackwell et al., 1995;
Blackwell et al., 1997).
Both active smoking and passive exposure to cigarette smoke are associated with an
increased risk of viral respiratory infection in adults and children (Hall et al., 1984). In
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this project, the separate effects of virus infection and exposure to cigarette smoke on
bacterial adherence were investigated. Two models were used. The first was based on
the well established associations between virus infection, exposure to cigarette smoke
and secondary bacterial infection of the respiratory system, e.g., pneumonia,
exacerbations of chronic bronchitis and otitis media. The second model was based on
more speculative associations between virus infection, exposure to cigarette smoke and
increased susceptibility to bacterial meningitis.
The classic example of influenza virus infection as a predisposing factor for bacterial
pneumonia has been studied in both epidemiological and experimental investigations
(Nugent and Pesanti, 1983). Influenza has also been implicated in epidemiological
studies of bacterial meningitis reflected in timing of outbreaks of meningococcal disease
in relation to prevalence of influenza in the community and antibodies to influenza A in
sera of patients with meningitis (Cartwright et al., 1991). Because influenza is less
common in infants and young children in which the major peak of meningitis occurs,
respiratory syncytial virus (RSV) was also examined in the model system. It is
implicated in susceptibility of children to several bacterial infections of the respiratory
tract (Hall, 1980) and annually affects the age range in which the majority of bacterial
meningitis cases occur.
1.2. Influenza viruses
Influenza viruses belong to the family Orthomyxoviridae and are separated into types A,
B, and C. Type C might represent a separate genus, as it does not demonstrate the
3
genetic variability seen in types A and B and rarely causes clinical disease. These
enveloped, negative stranded segmented RNA viruses are of similar size and
morphology and contain two types of membrane glycoproteins which project from the
virion surface. One glycoprotein, haemagglutinin, is responsible for attachment of
infecting viruses to host cell membranes. The other, neuraminidase, is involved in
release of virus from infected cells.
The most distinctive feature of the influenza viruses is the ability to change their
antigenic characteristics at irregular intervals. The antigenic changes are accounted for
by alterations in the amino acid sequence of haemagglutinin and / or neuraminidase.
With small changes (antigenic drift), previously formed antibodies can offer partial
protection; however, with major changes (antigenic shift), previously formed antibodies
do not "recognise" the variant and hence do not provide protection against reinfection
(Kilbourne, 1987 a; Glezen and Couch, 1989).
The influenza viruses are responsible for yearly outbreaks of infections that occur in the
winter or early spring. These outbreaks are usually widespread but vary considerably in
their extent and in the severity of clinical infections. Some epidemics are associated
with sharp increases in mortality, especially in the elderly. These yearly outbreaks
occur world-wide (Kilbourne, 1987 a; Glezen and Couch, 1989).
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1.2.1 Disease caused by influenza virus
The influenza viruses are responsible for a wide spectrum of clinical disease. The
characteristic "flu" symptoms (fever, headache, myalgia, malaise, anorexia, and
photophobia) occur early in the course of infection (Kilbourne, 1987 a; Glezen and
Couch, 1989). Cough becomes prominent thereafter. These are the classic findings in
influenza infections that aid identification of affected individuals during epidemics.
The influenza viruses may cause infection indistinguishable from those due to other
viruses. Such infections range from undifferentiated upper respiratory tract infections
to those that involve the lower respiratory tract in the form of croup, bronchiolitis, or
pneumonia. In small children, the primary site of involvement in most influenza
infections is the tracheobronchus. Clinical infections differ widely in severity and are
accompanied by a variety of complications.
Secondary bacterial infection is the most common, life-threatening complication of
influenza infection (Kilbourne, 1987 a; Glezen and Couch, 1989). The general clinical
picture is one of gradual improvement during convalescence with a sudden relapse
characterized by recurrence of fever, chest pain, and productive cough. At times this
biphasic pattern does not appear, and the secondary infection blends into the initial viral
infection. Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus
influenzae are the most common pathogens isolated in influenza-associated bacterial
pneumonia; Klebsiella pneumoniae, Streptococcus pyogenes, and Neisseria meningitidis
superinfections have also been reported (Leigh et al., 1991).
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Experimental studies in which animals were used have shown that bacterial
superinfection occurs after simultaneous inoculation of virus and bacteria or after
primary influenza virus infection followed by inoculation of bacteria into the respiratory
tract (Pio et al., 1985). Influenza-associated bacterial infections is particularly
prominent in developing countries where nasopharyngeal colonisation with S.
pneumoniae and H. influenzae is higher than in developed countries (Pio et al., 1985).
1.2.2 Factors that influence the course and outcome of influenza virus
infections
1.2.2.1 Immunity
Innate and immune responses to influenza virus infection are essential for limiting the
severity and duration of illness, as well as for protecting against subsequent infection by
an antigenically similar strain. Individuals who are immunocompromised from
congenital or acquired defects in the immune system or from immunosuppression by a
variety of conditions are more likely to have severe and prolonged illnesses with
influenza virus infection (Leigh et al., 1991).
1.2.2.2 Age
The influenza viruses commonly infect patients of all ages, probably because of the
changing antigenic structure of the viruses and the absence of protective immunity to the
new strains. For reasons that are not completely understood, individuals at the
extremes of age (infants and the elderly) are at increased risk for serious and even fatal
influenza infections (Kilbourne, 1987a; 1987b). The increase in mortality is
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particularly prominent in the elderly. Possible factors that could be important in this
group are waning of immune responsiveness and underlying cardiopulmonary
insufficiency. The clinical presentation of influenza infection in infants and young
children differs from that in older children and adults and often resembles that of
bacterial sepsis. Some studies have suggested that the course of illness and virus
shedding are more prolonged in infants than in older age groups. Studies in ferrets with
influenza infection also have demonstrated increased mortality among younger animals
(Collie et al., 1980). One of the proposed explanations for this high mortality is that
congestion of the small nasal passages of infant ferrets leads to complete nasal
obstruction and obstructive apnea (Sweet et al., 1988).
1.2.2.3 Cardiovascular disease
Several studies have demonstrated that underlying cardiovascular disease is a major risk
factor for severe influenza illness. In the 1957 epidemic, patients with heart disease,
most notably those with rheumatic heart disease, experienced a high mortality rate (as
high as 50%) and a high incidence of pneumonia (50%), both primary influenza
pneumonia and secondary bacterial pneumonia (Kilbourne, 1987a). Little is known
about the course of influenza in patients with congenital heart disease, but RSV
infections are particularly severe in patients with congenital heart defects, especially
those with pulmonary hypertension (MacDonald et al., 1982).
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1.2.2.4 Chronic lung disease
Patients with chronic lung diseases, specifically chronic bronchitis, bronchiectasis,
asthma, emphysema, and bronchopulmonary neoplastic disease, are at increased risk for
pneumonia and death from influenza infection (Kilbourne, 1987a). Several
mechanisms might be playing a role in increasing the severity of disease. The
underlying lung disease could limit respiratory reserve, thereby increasing the risk of
respiratory failure during influenza infection. In addition, many of these patients have
airway hyper-reactivity and impaired mucociliary clearance, which might increase the
likelihood of their developing bronchospasm, mucus plugging, and secondary bacterial
pneumonia in association with influenza virus infection (Leigh et al., 1991).
1.2.2.5 Malnutrition
Malnutrition is a major risk factor for acute respiratory illnesses, leading to increased
incidence of disease and mortality (Pio et al., 1985; Stansfield, 1987). The effects of
malnutrition on immune function have been reviewed extensively (Rochester, 1984;
Martin, 1987). Protein-calorie malnutrition results in major impairment of cell-
mediated immunity and virus infections that are controlled by cell-mediated responses
are more prevalent and severe among the malnourished. Humoral immunity and
phagocytic function of polymorphonuclear leukocytes are impaired in severely
malnourished individuals but not to the extent that cell-mediated immunity is impaired.
Vitamin A deficiency has been identified as a nutritional determinant influencing
incidence of disease and mortality from acute respiratory illnesses in developing
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countries (West et al., 1989). Vitamin A is important for maintenance of epithelial
integrity; experimental vitamin A depletion results in squamous metaplasia of airway
epithelium and loss of ciliated and goblet cells. In addition, vitamin A deficiency
impairs humoral and cell-mediated immunity, phagocytosis, and delayed
hypersensitivity. Other nutritional factors that appear to be important are prenatal
nutrition and breast feeding. The risk of mortality from respiratory infections is higher
in infants of low birth weight than in infants of higher birth weight (Pio et al., 1985).
Likewise, infants who are not breast-fed are more likely to die of a respiratory illness
than are those who are breast-fed (Stansfield, 1987).
1.2.2.6 Infections due to other micro-organisms
Preceding or coexisting infections with other micro-organisms could influence the
course of influenza infections. Colonisation or infection of the airways with bacteria
during influenza infection increases the risk of a secondary bacterial pneumonia. Other
infections could impair host defense mechanisms that are important in controlling
influenza disease. Primary infections by viruses, most notably human
immunodeficiency virus (HIV), can cause immunosuppression (Rouse and Horohov,
1986). HIV infection is prevalent world-wild and has been shown to influence
immunity to influenza (Ragni et al., 1987). Other viruses capable of inducing
immunosuppression include measles, Epstein-Barr virus (EBV), cytomegalovirus




RSV belongs to the genus Pneumovirus in the family of Paramyxoviridae. It is a large
enveloped, negative-stranded RNA virus. The virus particles are pleomorphic,
approximately 80-350 nm in diameter or filaments of up to 10 urn in length. The
virions assemble at circumscribed regions on the plasma membrane of the infected cell
and mature by budding during which intracellular nucleocapsid is packaged within an
envelope that is derived from the host cell membrane (Bachi, 1988). The envelope
contains spike-like projections spaced at 6-10 nm intervals composed of the major
structural glycoproteins G and F which mediate viral attachment (G) (Levine et al.,
1987) and fusion and penetration (F) (Walsh and Hrusks, 1983). These glycoproteins
are transported to the cell membrane and inserted in the lipid bilayer (Satake et al.,
1985). Two antigenically distinct types of RSV, designated A and B subgroups based
on variation in G glycoprotein of RSV have been recognised (Anderson et al., 1985;
Johnson et al., 1987).
1.3.1 Age
RSV is a major cause of respiratory infections in infants and young children (Avila et
al., 1989; Monto and Lim, 1986). In children with respiratory disease, RSV is the most
frequently isolated virus (Huq and Rahman, 1990; Nicolai and Pohl, 1990). Over 90%
of all these RSV infections are observed in children less than 2 years of age (Avila et al.,
1989; Huq and Rahman, 1990). Most children are infected with RSV by the age of 2
years, but the infections can occur throughout life and have been reported in
adolescents, adults and elderly people (Finger et al., 1987; Belshe et al., 1978; Englund
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et al., 1991). Taylor and colleagues (1989) studied over 500 infants from two
epidemics and found that patients with subgroup A infections tended to be significantly
younger (22 weeks) than those with subgroup B infections (28 weeks). Tsutsumi and
colleagues (1988) studied nine epidemics of RSV in Japan and also found that children
infected with virus of subgroup A tended to be younger. The study by Hall and
colleagues (1990), a longitudinal study over 15 years on RSV isolates from 1209
hospitalised and ambulatory children, did not find a significant age difference between
patients infected with subgroup A and those infected with subgroup B. All the studies
used the same methods for detection of the virus (direct immunofluorescent antibody
technique and ELISA).
RSV is also a significant cause of serious lower respiratory tract infection in
immunocompromised adults and the elderly (Falsey et al., 1995).
1.3.2 Geographical distribution and seasonality
RSV infections have been reported world wide (Finger et al., 1987; Sung et al., 1987;
Hall et al., 1990; Huq and Rahman, 1990; Nicolai and Pohl, 1990). There is a definite
seasonal periodicity in RSV infections. In zones with a temperate climate, the peak
incidences of RSV infections usually occur yearly during the autumn, winter and early
spring (Anderson et al., 1990). The epidemic lasts 5 to 6 months and peaks during the
third or fourth month, the actual month of peak infection varies a little from year to year.
Fewer studies have been reported from sub-tropical countries (Sung et al., 1987;
Nwanko et al., 1988; Tantivanich et al., 1984). In these countries, correlations of
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incidence of infection with rainfall have been observed. It could be that factors such as
cold weather in temperate zones or rain in sub-tropical areas lead to close contact
indoors and enhanced transmission of the virus.
1.3.3 Incidence and prevalence of primary infection
Among children in hospital with pneumonia, RSV could be recovered in 9 to 39% of
cases (Sung et al., 1987; Nicolai and Pohl, 1990; De Silva and Hanlon, 1986; Kim et al.,
1973). Among those with bronchiolitis, RSV was recovered in 27-70% of the children.
Most infants become infected with RSV during their first year of life (Kim et al., 1973),
and 25-50% have antibodies to RSV (Parrot et al., 1966). Others studies reported that
95-98% of children have antibodies to RSV at the end of their third year of life
(Brussow et al., 1991; Fernald et al., 1983). Differences in reliability and accuracy of
tests may underlie these different observations, particularly results of earlier studies with
less accurate means of diagnosis of infection.
1.3.4 Transmission
RSV infections are transmitted by large droplets through fomite contamination, or by
direct contamination with infected secretions. Close contact appears to be necessary for
infection to spread from one person to another. The most important route of
transmission appears to be self-inoculation with fingers contaminated with infected
secretions (Hall, 1990). The fingers transmit the virus to the nasal mucosa or
conjunctivae from which the virus spreads to the upper respiratory tract.
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The incubation period is usually 2-8 days (Hall, 1990). The infection spreads to the
lower respiratory tract within a few days of the onset of symptoms. In a study by Waris
and colleagues (1992), 40-60% of the patients stopped shedding RSV 8 to 10 days after
the onset of illness. Some infants can shed RSV for up to 3 or 4 weeks or longer.
Longer periods of virus shedding have been noted in immunosuppressed children, and
shorter durations in older children and adults (Hall et al., 1976).
1.3.5 Risk factors for RSV infection
Several risk factors for RSV lower respiratory tract infection have been identified. In
the early months of life, the infection is more common in males (Ruuskanen and Ogra,
1993). RSV infection is more common in: children born during the summer months
approximately 6 months before the outbreak; those sharing a bedroom with other
children (especially when there are two or more sharing the room); day-care settings;
and infants of mothers with lower educational levels (Holberg et al., 1991;
McConnochie and Roghmann, 1986; Anderson et al., 1988). Importantly, breast¬
feeding for longer than 1 month has a protective role, especially for those infants whose
mothers are of lower socio-economic status. Infants with a low titre of RSV antibody
in cord serum and minimal breast-feeding are especially at risk for RSV infection of the
lower respiratory tract (Holberg et al., 1991).
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1.4 Virus infection and susceptibility to bacterial disease
While influenza and RSV affect different age ranges, there are several bacteria that are
commonly associated with diseases for which these viruses are predisposing factors.
These can be found as part of the normal respiratory flora; therefore, it is important to
examine ways in which virus infection could lead to disease, e.g., enhanced density of
colonisation.
RSV is a major cause of hospitalisation in infants during the first 6 months of life and
secondary bacterial infections such as acute otitis media and pneumonia are common
(Ruuskanen and Ogra, 1993). In a Finnish study, RSV infections were associated with
significant rises of antibody titres to H. influenzae, Moraxella catarrhalis and
pneumococcal antigens (Korppi et al., 1989). In the United States, RSV infection was
associated with isolation of Bordetella pertussis from infants during a winter outbreak
(Nelson et al., 1986), and recent studies indicate that RSV infection was significantly
associated with invasive pneumococcal disease in both adults and children (Kim et al.,
1996).
Many of the host's defenses against bacterial infections of the respiratory tract can be
altered by influenza virus infections (Couch, 1981). Influenza infection causes
desquamation of ciliated cells and altered mucous secretion, compromising the
efficiency of mucociliary clearance by the airways. Bacterial adherence to influenza-
infected cells is enhanced by mechanisms that are not clear. The combination of
impaired mucociliary clearance and enhanced binding of micro-organisms, inhaled or
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aspirated coincident with an influenza infection, will be retained in the lung and cause
pneumonia.
Influenza virus infection causes impairment in the function of alveolar macrophages
(Jakab, 1982), reduction in chemotaxis of monocytes (Kleinerman et al., 1975) and
reduction in lymphocyte responsiveness and proliferation of T-suppressor cells
(Gardner, 1981). It also interferes with the chemotactic and phagocytic function of
polymorphonuclear leucocytes (PMN) (Larson et al., 1980; Martin et al., 1981; Leigh et
al., 1991). Similar effects on the function of PMN were found with RSV (Craft et al.,
1976).
1.5 Air pollutants and infectious diseases
Exposure to air pollutants, especially indoor air pollutants, has been identified as a risk
factor for respiratory illnesses (Samet et al., 1987; Samet et al., 1988). This is
particularly important in the developing world (Pio et al., 1985; Stansfield, 1987).
Products of combustion from fossil fuels, wood, and dung are major indoor air
pollutants in developing countries where exposure levels to indoor air pollutants,
especially for children, are much greater than in technologically advanced countries
(Samet et al., 1987). The incidence of both acute respiratory infections and chronic
respiratory symptoms is increased in individuals exposed to certain agents. Many
pollutants, such as ozone, cigarette smoke, wood smoke, and nitrogen dioxide, a product
of burning fuels, increase airway reactivity, which in turn might increase the
bronchospasm associated with respiratory infections. Chronic irritation of the airways
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by pollutants results in chronic bronchitis and impaired mucociliary clearance,
predisposing the airways to infection. A study by Goings and colleagues (1989)
demonstrated that exposure to nitrogen dioxide increases susceptibility to influenza
virus infection.
Environmental tobacco smoke, a complex mixture of exhaled mainstream smoke and
non-inhaled side-stream smoke, also contributes to respiratory morbidity of children
(Chen et al., 1986). Tobacco combustion produces multiple toxic compounds (Guerin
et al., 1992). Although environmental tobacco smoke differs from mainstream smoke
in several ways, it contains many of the same toxic substances. Infants and toddlers
may be especially at risk when exposed to environmental tobacco smoke (US National
Research Council, 1986). Exposure to toxic compounds in infancy is particularly
problematic because early lung development appears to be a critical determinant of
respiratory health (Martinez et al., 1988).
1.5.1 Cigarette smoke and susceptibility to infection
1.5.1.1 Respiratory infection in adults
Active smoking is associated with an increased risk of respiratory tract infections in
adults. Aronson and colleagues (1982) showed that young smokers had an
approximately two fold greater risk of developing an infection compared to non-
smokers. Smokers were also more likely to have a lower respiratory tract infection and
they remained symptomatic for a 25% longer period. Kark and colleagues (1982)
suggested a link between smoking and contracting HI N1 influenza virus in a
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susceptible population of young men. Within this population, the severity of disease
was considerably greater among smokers. Smokers also have an increased risk of
developing the common cold, smoking being related to both the probability of infection
and of developing symptoms (Cohen et al., 1993). Cigarette smoking has been shown
to be the most common cause of chronic bronchitis, and heavy smokers are particularly
susceptible to lower respiratory tract infections caused by H. influenzae, S. pneumoniae,
S. aureus and M. catarrhalis (Cazzola et al., 1990).
An association has also been demonstrated between susceptibility to several non¬
respiratory infections and smoking. Smoking has been shown to confer a two fold
increase on a woman's risk of developing pelvic inflammatory disease, a severe upper
genital tract infection caused mainly by Streptococcus intermedius or Neisseria
gonorrhoeae (Scholes, 1992). It has also been shown that cigarette smoking will
accelerate progression to AIDS in HIV positive individuals, and that heavy smokers are
over three times more likely to develop Pneumocystis carinii pneumonia than light
smokers (Nieman et al., 1993).
1.5.1.2 Adults and Passive Smoking
There is very little information about the effects of passive smoking related to adult
respiratory infections, but a strong association has been shown between passive
smoking, especially in the home, and lung cancer (Spitzer et al., 1990). Passive
smoking has been related to a higher incidence of both colds and chronic obstructive
pulmonary disease in adult non-smokers (Cazzola, 1990). Shepherd (1992)
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hypothesised that a non-smoker who lives with a smoker will be more likely to develop
a respiratory tract infection as the smoker himself has an increased risk of disease, thus
increasing the exposure of the non-smoker to respiratory pathogens. Chronic exposure
of a non-smoker to environmental tobacco smoke is thought to produce effects similar
to those associated with active smoking, e.g., chronic bronchitis (Robbins et al., 1993).
1.5.1.3 Children and Passive Smoking
Substantially more information has been published concerning the association between
passive smoking and children's respiratory health. The strongest associations appear to
be found between maternal smoking and the respiratory health of children less than two
years old (Pershagen, 1986); but even in later childhood (5-11 years old), the risk of
respiratory tract infections due to passive smoking is still increased (Chen and Rona
1991). A child's exposure to cigarette smoke, especially in the home, might be for up
to eighteen years and this early exposure to smoke is believed to be crucial in
determining the long term health of the child (Whidden, 1993).
Respiratory infections are frequent in childhood, and about 30 % of all infants are
treated for bronchiolitis, croup or pneumonia (Wright et al., 1989). Bacterial and viral
infections of the respiratory tract are more common in children exposed to cigarette
smoke (Colley et al., 1974, Ogston et al., 1987), and they are four times more likely to
be admitted to hospital than children whose parents do not smoke (Berg et al., 1991).
Ogston and colleagues (1987) found parental smoking was associated with higher
respiratory and alimentary illnesses in the first year of life, and there was evidence of
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lower incidences of infection among the breast fed compared with bottle fed infants.
Alimentary illness was associated with mother's smoking habit, whereas respiratory
illness was associated with smoking by either parent. Lower respiratory tract infections
such as pneumonia and bronchitis are also more common in a child whose parents
smoke (Chen et al., 1986; Weiss et al., 1983). Ear infections, especially otitis media
caused by H. influenzae and S. pneumoniae have been demonstrated to be more
common in children of smokers than those of non-smokers (Kraemer et al., 1983).
Maternal smoking during pregnancy might predispose a child to respiratory infections in
early life by causing congenital damage to the developing respiratory system, interfering
with the immune system or causing a secondary immunodeficiency (Taylor and
Wadsworth, 1987). Cigarette smoking during pregnancy had been associated with
reduced birth weight, and low birth weight was associated with a wide range of
defective immune functions that might predispose to respiratory infections (Taylor and
Wadsworth, 1987). Infants exposed to maternal smoking had an increased incidence of
lower respiratory tract infection (Fergusson et al., 1981). This effect showed a dose-
response relationship to maternal smoking and decreased after the first year of life.
Infants with bronchiolitis before the age of 2 years were 2.4 times more likely to have
been exposed to maternal smoking than infants who did not develop a lower respiratory
tract infection (McConnochie et al., 1986).
A study by Wright and colleagues (1991) found that infants whose mothers smoked at
least one package of cigarettes per day had 2.8 times the risk of developing a lower
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respiratory infection. Children hospitalized for acute lower respiratory illness before
the age of 2 are 1.8 times as likely to live with smokers than control subjects
hospitalised for non-respiratory illness (Hall et al., 1984). Considering the substantial
morbidity, and even mortality, of acute respiratory illness in childhood, a doubling in
risk attributable to passive smoking clearly represents a serious paediatric health
problem (US. National Research Council, 1986).
1.5.2 How does cigarette smoke affect the respiratory tract ?
1.5.2.1 Prenatal effect of smoking
The manner in which passive exposure to environmental tobacco smoke leads to
increased lower respiratory infection risk is unknown. Prenatal effects of maternal
smoking on the lung have been demonstrated by Hanrahan and colleagues (1992) who
found that infants born to mothers who smoke have reduced forced expiratory flows
(measured in litres / min with a Peak Flow Meter). The degree of reduction was
correlated with increasing maternal urine cotinine/creatinine ratios during pregnancy.
Subsequent lung dysfunction and respiratory illness could thus begin by in utero
exposure to cigarette smoke, with alteration of the developing lung (Martinez et al.,
1988). Children whose mothers smoked only after pregnancy were still more likely to
develop acute respiratory illness (Woodward et al., 1990).
1.5.2.2 Bacterial adherence
Bacterial adhesion is an important factor favouring persistence and colonisation of the
respiratory tract (Reynolds, 1987; Plotkowski et al., 1993). Most studies have
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investigated bacterial adhesion of S. pneumoniae and H. influenzae to oropharyngeal
and buccal cells, either to exfoliated cells or to nasopharyngeal mucosal biopsies.
Adhesion has also been demonstrated to exfoliated human bronchial cells for B.
pertussis (Toumanen et al., 1988).
Smokers have been shown to have an enhanced adherence of S. pneumoniae to buccal
cells (Raman et al., 1983; Mahajan and Panhotra, 1989), and smokers with chronic
bronchitis appear to have increased adherence of H. influenzae to their pharyngeal cells
(Fainstein and Musher, 1979).
1.6 Smoking and Meningococcal Disease
The risk factors for meningococcal disease include close contact with a case,
overcrowded accommodation, poverty and lower social class, and passive exposure to
cigarette smoke (Stuart et al., 1988). In Britain, smoking is more prevalent among both
men and women in partly skilled or unskilled occupations compared with those in
professional classes (Wald et al., 1988).
Although there is no direct association between meningitis and smoking, there is a
connection between cigarette smoking and meningococcal colonisation of the
nasopharynx which is not dependent on age, sex, or social class. The association
between smoking and meningococcal colonisation is highly significant and appears to
be greater among heavier smokers (Stuart et al., 1989; Blackwell et al. , 1992).
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While there is no association with active smoking and meningitis, children who live in
households in which there are smokers are at increased risk of invasive meningococcal
disease (Stuart et al., 1988).
Cigarette smoking is suggested to reduce nasopharyngeal mucosal defences against
meningococcal invasion (Stuart et al., 1988; Haneberg et al., 1983). Since cigarette
smokers are more likely to be meningococcal carriers (Stuart et al, 1989; Blackwell et
al., 1990; Blackwell et al., 1992), young children living in households with smokers
would have more frequent contact with carriers, greater chances of acquiring
pathogenic meningococci, and hence higher attack rates (Stanwell-Smith et al., 1994).
Studies among Greek school children found that in children in households where the
mother or other "carer" smoked, the proportion of carriers was significantly higher
compared with children from households where no one smoked (Kremastinou et al.,
1994).
1.7 Experimental models for examination of bacterial binding
Many experimental models have been used to investigate virus induced alterations in
attachment and invasion by bacteria. Since human volunteers are rarely used as models
for studies of bacterial pathogens, in vitro assays on human cells and cultures of cells
and organs from human sources are employed, but there are some limitations.
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1.7.1 Buccal and pharyngeal epithelial cells
Human buccal epithelial cells have been used in many studies of bacterial attachment
(Craven et al., 1980; Salit and Morton, 1981; Stephens, 1989). Easy availability of the
cells is offset by the fact that they are not uniform in size, degree of maturity or viability.
They might already have bacteria attached to their surface from oral flora which can
affect the results of binding assays. The cells are not the normal site of attachment of
many bacterial pathogens. Bacteria can attach to these cells, but unlike in vivo target
cells, they do not penetrate the membrane of these cells. Different samples of buccal
epithelial cells can vary in surface chemistry due to molecules from the food taken just
before sampling or to inherited differences between individuals, e.g., blood groups.
Variations in binding of bacteria to cells from the same donor have been shown
(Tramont and Wilson, 1977). Use of buccal epithelial cells to study the effect of virus
infection on bacterial binding is further hindered by the inability of these cells to be
infected with respiratory viruses.
Pharyngeal cells can also be obtained relatively easily. Their use for in vitro bacterial
attachment assays is limited by the factors above. Pharyngeal cells, however, are
relevant to the study of the viral-bacterial association since virus-infected cells can be
obtained from virus-infected hosts. Fainstein and colleagues (1980) compared bacterial
binding to pharyngeal cells obtained from 21 individuals who had nasopharyngeal
symptoms of infection but were culture negative for influenza virus with cells from 10
healthy subjects infected with an experimental vaccine strain of influenza virus and cells
from 21 age-matched, symptom-free controls to study the effect of viruses on bacterial
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binding. There was increased binding of S. aureus to the cells of virus infected subjects
compared with those from the uninfected group.
1.7.2 Tissue / organ cultures
Nasopharyngeal tissues from adenoids (Stephens, 1989; Stephens and Farley 1991) and
nasal tissues from inferior turbinates resected from patients with non-allergic symptoms
(Read et al., 1991) were obtained for the study of pathogenesis of N. meningitidis and H.
influenzae infections. This model might accurately reflect the events happening in
natural infections. Its major disadvantages that the tissues are difficult to obtain. The
features related to genetic make up of the donor and the disease for which the donor was
treated are reflected in the resected tissue. Patients undergoing surgery are presumably
free of viral infections. So far, no attempt has been made to infect these organ cultures
with viruses in vitro.
Organs, however, can be used from animals naturally or experimentally infected with
viruses. Tracheas from mice experimentally infected with influenza virus A and killed
on 2nd, 4th or 6th day post-infection were exposed to a suspension of radiolabeled S.
pneumoniae for 90 minutes. In comparison with radioactivity detected on the tracheas
from uninfected mice, that on the influenza infected mice was significantly increased.
The bacteria were attached to flat-surfaced epithelial cells which replaced ciliated
columnar epithelial cells in the mucosa of the infected mice and to basement membrane
on the denuded areas of the tracheas, as shown by electron microscopy (Plotkowski et
al., 1986). Organ cultures of tracheas from chinchillas infected with influenza A virus
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have been used to study the effect of virus infection on the tracheal histopathology and
on binding of H. influenzae. Non-typable strains bound more effectively compared with
type b H. influenzae (Hib). Increased numbers of Hib were recorded in the nasal
washings from infant rats that had been inoculated with influenza A virus followed by
bacteria 48 hours post-infection (Michaels and Myerowitz, 1983). Binding of non-
typable H. influenzae to chinchilla tracheal tissue infected with influenza A virus was
decreased at 72 hr post-infection (Bakaletz et al., 1988).
Use of organs dissected from animals and animal models is, however, not relevant for
assessment of the effect of viral infections on the bacteria causing meningitis since most
common bacteria responsible for the disease (Hib, meningococci and pneumococci) are
exclusively human pathogens. Animals, however, have been used to study isolated
events in the pathogenesis of the disease.
1.7.3 Cell culture models
Cell culture models have been used for the study of cytotoxicity caused by bacteria,
bacterial attachment, and the effect of viral infections on this attachment. Primary cells
have been employed for these studies but are difficult to establish and maintain. No
significant difference was observed in the binding of S. aureus and other bacteria
causing bovine respiratory diseases to cells from bovine embryonic lung infected with
bovine parainfluenza virus (Toth and Gates, 1983). A primary endothelial cell culture
established from newborn umbilical cord was used to examine the binding of S. aureus
to human endothelium in the pathogenesis of bacterial endocarditis (Ogawa et al.,
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1985). Complications such as variations in the source of the tissues and, often,
pathology of the organ from which the tissue in question is resected make the primary
cell culture model less ideal for studies of virus-bacterium interaction.
Continuous cell lines of tumour origin are easy to handle and can be maintained
aseptically in standard conditions. Stephens (1989) reviewed the use of different
models including HeLa and the HEp-2 cells (human epithelial cell lines) in studies of
the binding of Neisseria species. Continuous cell lines were found suitable for the
studies. Chang epithelial cells (derived from human conjunctiva) were used to
determine the role of bacterial pili in the attachment of H. influenzae (St. Geme and
Falkow, 1990). HeLa and Detroit cells (human epithelial cell line) were used to study
the effect of cellular infection with measles virus and adenovirus on binding of bacteria
(Selinger et al., 1981).
Sanford and colleagues (1978) used a continuous line of Madin-Darby canine kidney
(MDCK) cells to examine the effect of influenza virus infection of the cells on the
attachment of streptococci. The bacteria attached to the infected cells only. The
attachment could be blocked by pre-treatment of the infected cells with an antibody to
the viral glycoproteins expressed on the surface of the infected cells indicating that the
viral glycoproteins might be the receptors for the bacteria. Staphylococci did not attach
to MDCK cells in this study, but attachment was observed in a later study by the same
group (Sanford et al., 1986). The cells in this study were used to analyse the effect of
influenza virus infection, the effect of enzymes and changes in other conditions in the
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assay on the attachment of staphylococci. The reason for the discrepancy between the
two findings for the attachment of staphylococci to MDCK cells was not discussed in
their report.
Previous work in this department found that compared with uninfected HEp-2 cells,
HEp-2 cells infected with RSV-A showed enhanced binding of N. meningitidis and H.
influenzae type b (Raza et al., 1993). In addition it was found that glycoprotein G of
RSV subgroup A is an additional receptor for meningococci (Raza et al., 1994). As the
glycoprotein G of the two subgroups vary (Anderson et al., 1985; Johnson et al., 1987),
examination of the effect of RSV-B on bacterial binding was needed.
1.7.4 Detection of bacterial binding
Methods commonly used for assessing bacterial binding to cell cultures include: light
microscopy of stained monolayers of the cells (Selinger et al., 1981; Musher and
Fainstein, 1981); fluorescence microscopy (Sanford et al., 1978); interference contrast
microscopy (Andersson et al., 1986); electron microscopy (Stephens et al., 1983);
radioassays (Ogawa et al., 1985; Sanford et al., 1986); and the pour plate method,
counting colony forming units of bacteria in the supernatant after incubation with cell
monolayers (Ogawa et al., 1985).
Direct microscopy is simple, cheap and allows visualisation of the process being
studied. It is, however, time consuming, not accurate for quantitation of large numbers
of bacteria or for large experiments. Radioassays are also limited in value since the
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manipulation of bacteria for the uptake of the label can affect bacterial binding.
Leakage of radioactive material from the labelled bacteria and background disturbance
in detection of radioactivity in these assays also make the assessment more complicated.
The use of electron microscopy is mainly limited to the study of mechanisms of
bacterial attachment to the cells and bacterial pathogenicity. It cannot be used to
demonstrate adherence with confidence since the results cannot be generalised due to
patchy distribution of bacteria bound to cells and the area of tissue visualised by the
microscope is limited.
Flow cytometry has been applied to studies of binding of both Gram-negative and
Gram-positive bacteria (Rahat, 1990; Raza et al., 1993; Saadi et al., 1993; Saadi et al.,
1996; Alkout et al., 1997). The flow cytometer can detect fluorescein-labelled bacteria
bound to cells. The proportion of cells with FITC-labelled bacteria attached and mean
level of fluorescence can be obtained using this method. Although mean fluorescence
recorded on cells is proportional to the numbers of bacteria attached, it cannot be
expressed in terms of numbers of bacteria because the level of fluorescence obtained
with one bacterium on a cell is difficult to determine accurately. The method is,
however, rapid, objective, precise and analyses a large number of cells in each sample
and large numbers of samples can be assessed in each experiment.
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1.8 Aims of the study
Epidemiological studies on nasopharyngeal flora of infants found no association
between frequency of isolation of a number of species associated with respiratory tract
infection or N. meningitidis with symptoms of virus infection or exposure to cigarette
smoke (MacKenzie et ai, 1994; MacKenzie et ai, 1996). The main aim of this study
was to assess the effects of virus infection and smoking on density of bacterial binding
as this has been demonstrated to be associated with disease (Beachey, 1981). Smoking
and exposure to smoke are both predisposing factors for respiratory virus infection, but
effects of virus infection or exposure to cigarette smoke on bacterial attachment to
epithelial cells were assessed separately. Two groups of bacteria were examined:
1) respiratory bacteria for which there is epidemiological and experimental evidence that
exposure to cigarette smoke and viral infection contribute to susceptibility to infection;
2) bacteria associated with meningitis for which epidemiological studies have provided
evidence that these two factors enhance susceptibility to disease.
The objectives of the study were:
1-to determine if, as found with RSV subgroup A, infection of HEp-2 cells with RSV
subgroup B enhances bacterial binding;
2-to determine if there is increased binding of Gram-positive species associated with
meningitis and species associated with secondary respiratory infections or exacerbation
of chronic bronchitis to RSV infected cells;
3-to determine if binding of bacteria to influenza virus infected cells was increased in
the HEp-2 cells model used for RSV;
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4-to assess changes in surface components of virus infected cells that could affect
bacterial binding;
5-to determine if there is enhanced binding of bacteria associated with meningitis or
respiratory diseases to cells of smokers;




General Materials and Methods
All chemicals were of Analytical Grade and were obtained from BDH Chemicals Ltd.,
UK unless otherwise indicated.
2.1 Phosphate-buffered saline (PBS) for washing bacteria
PBS contained 8 mM NaHP04, 1 mM KH2P04, 3 mM KC1 and 0.15M NaCl. The pH
was adjusted to 7.2
2.1.1 Dulbecco's PBSA for washing cell lines
Dulbecco's PBS prepared from concentrated PBS (10X) (Gibco) without calcium and
magnesium was used for washing the cells.
2.2 Reagents used for determination of bacterial binding
2.2.1 Fluorescein isothiocyanate (FITC) buffer
The buffer contained sodium carbonate (0.05 M) and sodium chloride (0.1 M). The pH
was adjusted to 9.2
2.2.2. FITC Labelling of bacteria
FITC (Sigma, Poole, Dorset, UK) was used for labelling the bacteria in all assays. The




Buffered paraformaldehyde (1% w/v) was prepared by adding sodium cacodylate (1%
w/v) to paraformaldehyde (1% w/v). The pH was adjusted to 7.2
2.3 Bacterial culture
2.3.1 Media
Modified New York City medium (MNYC) (Cherwell Laboratories Ltd., UK) was used
to culture Neisseria species. S. pneumoniae was grown on Columbia blood agar, H.
influenzae isolates on chocolate agar with horse blood, B. pertussis on charcoal agar and
S. aureus on nutrient agar. The prepared media were obtained from Oxoid Unipath Ltd,
UK.
2.3.2 Maintenance and storage of bacteria
Bacterial cultures were prepared by reconstituting lyophilized strains in distilled water
for 20 min and plating them on appropriate media. For storage, colonies were
emulsified in Microbank beads (Pro-Lab Diagnostic, Ontario, Canada) and kept at -
20°C. A fresh bead was used to inoculate plates for each set of experiments.
2.4 Tissue culture cell lines and growth media
2.4.1 HEp-2 cells
HEp-2 cell line (Flow Laboratories) was used in the studies. This continuous cell line
consists of transformed epithelial cells originating from a human laryngeal carcinoma.
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2.4.2 MDCK cells
The MDCK cell line (European Collection of Animal Cell Cultures, CAMR, Salisbury,
UK) was used in the studies for the growth of influenza virus.
2.4.3 THP-1 cells
The THP-1 (human monocyte / macrophage) cell line used in some experiments was
obtained from European Collection of Animal Cell Cultures, CAMR, Salisbury, UK.
2.4.4 THP-1 growth medium
RPMI 1640 medium (Gibco, Paisley, UK) supplemented with foetal calf serum (FCS)
(Gibco) (10%), 100 U ml 1 penicillin G, 100 gg ml ' streptomycin sulphate (Sigma,
Poole, Dorset) and lm M L-glutamine (Gibco) was used to grow the THP-1 cells.
2.4.5 HEp-2 cells growth medium (GM)
HEp-2 cells were grown in GM which consisted of Eagle's minimal essential medium
(Gibco) supplemented with FCS (Gibco) (10%), NaHCOs (0.85gl '), L-Glutamine
(2mM), streptomycin (200 pgl ') and penicillin (100 IU ml '). The pH of the final
preparation was adjusted to 7.4 with 1 N NaOH.
2.4.6 Cell maintenance medium (MM)
MM consisted of the same constituents as GM except the quantity of FCS was reduced
to 1%. In some assays involving live bacteria, MM without antibiotics was used.
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2.4.7 Growth of HEp-2 cell line
Confluent monolayers of HEp-2 cells were obtained in tissue culture flasks by growth in
GM. The monolayer was rinsed twice with PBSA. A solution (2 ml) of 0.05% trypsin
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(w/v) and 0.02% EDTA (v/v) (Gibco) was applied to the monolayer of cells in a 75 cm
flask for 4-6 min at 37°C to prepare a suspension for the next passage. The effect of
trypsin / EDTA on the cells was terminated by suspending the cells in 5-10 ml of GM.
Cells were counted by preparing a dilution (1/10) of the cell suspension in 0.5% trypan
blue (w/v) in physiological saline (Northumbria Biological, UK) and viable cells
counted by light microscopy using an improved Neubauer counting chamber. Cells
from freshly confluent monolayers (4xl06 ml"1) were suspended in 1 ml of GM with
10% dimethyl sulphoxide (DMSO) (Sigma) and stored in liquid nitrogen following
gradual cooling to -70°C. Frozen cells were resuscitated by rapid thawing at 37°C for
further use.
2.5 Standardisation of respiratory syncytial virus (RSV)
2.5.1 Plaque assay
2.5.1.1 Solutions
Overlay medium (OLM) was prepared by adding methyl cellulose 3% w/v (Sigma) in
Hank's buffered salt solution (Gibco) and NaHC03 (2 g I ') to maintenance medium in a
proportion of 1 : 3
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2.5.1.2 Method
HEp-2 cell monolayers were obtained by seeding 24-well tissue-culture plates (Costar)
which were incubated in 5% CCL in air for 24 hr. Ten-fold dilutions of the virus
suspension to be assayed were distributed to wells in quadruplicate (200 p.1 / well) and
adsorbed to monolayers for 1 hr at 37°C. The supernatant was removed from the wells
and 1 ml of overlay medium added to each well. The plates were incubated in 5% CO2
at 37°C for 3-4 days until syncytia / plaques appeared in the monolayers. The
monolayers were fixed with formol saline (10% v/v) for 10 min and staining solution
was used to examine cell monolayers for syncytia and plaque formation. The staining
solution contained crystal violet (0.13% w/v) and formalin (5% v/v) in normal saline.
After 20 min the wells were washed with tap water. The monolayers were examined
for plaques by inverted light microscopy.
2.6 Immunofluorescence reagents for detection of RSV or influenza
infected cells
2.6.1 RSV
The RSV reagent (Imagen, Dako Diagnostics Ltd, UK) contains monoclonal antibodies
conjugated to FITC. The conjugated antibodies bind specifically to viral antigens
present in all human RSV. The reagent was used in a one-step direct
immunofluorescence technique. Coverslips of fixed cell preparations (fixed in acetone
for 10 minutes) were incubated with 10 |il of the reagent for 15 minutes at 37°C in a
moist chamber. The excess reagent was removed by gently washing the slide in an
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agitating bath containing PBS for 5 minutes. The coverslip was mounted and examined
using fluorescence microscopy. Within the cells, RSV antigens showed bright green
granular cytoplasmic fluorescence which contrasts with the red background staining of
uninfected cells revealed by the Evans blue counterstain in the reagent. Positive control
slides containing fixed HEp-2 cells infected with RSV provided with the reagent were
used as control.
2.6.2 Influenza virus
The reagent for detection of influenza A (Imagen, Dako) contains monoclonal
antibodies specific for the virus conjugated to FITC. The reagent was used in a one-
step direct immunofluorescence assay. Coverslips of fixed cell preparations were
incubated with 10 pi of the reagent for 15 minutes at 37°C in a moist chamber. The
excess reagent was removed by gently washing the slide in an agitating bath containing
PBS for 5 minutes. The stained area was mounted and examined using fluorescence
microscopy. Within the cytoplasm and nucleus of the cells, the influenza A virus
antigens were detected by characteristic bright green granular fluorescence which
contrasts with the red background staining of uninfected cells. Positive control slides
containing fixed monkey kidney cells infected with influenza A provided with the
reagent were used as control.
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2.7 Bradford reagent and standard for protein estimation
Bradford reagent was prepared from Commasie Blue G250 ( 0.01% w/v) (Sigma),
ethanol (4.7% w/v) and phosphoric acid (8.5% w/v) in distilled water. Bovine serum
albumin was used as the standard for each experiment.
2.8 Buffers and solutions used for enzyme linked immunosorbent
assays (ELISA)
2.8.1 Coating buffer
Coating buffer consisted of sodium carbonate (15 mM), sodium bicarbonate (35 mM)
and sodium azide (3 mM) (pH 9.6).
2.8.2 Washing buffer
Washing buffer was prepared by adding bovine serum albumin (BSA) (Sigma) 0.1 %
(w/v) and Tween-20 (0.05 % v/v) to PBS (pH 7.2). The buffer was used for all washing
procedures during the assay.
2.8.3 Blocking buffer
Blocking buffer contained 1 % (w/v) BSA in 0.01 M PBS (pH 7.2).
2.8.4 Phosphate citrate buffer
Phosphate citrate buffer contained sodium hydrogen phosphate (0.1M) and citric acid
(0.1 M) (pH 5).
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2.8.5 Substrate solution
The substrate solution used to detect horseradish peroxidase (HRP) labelled antibodies
contained 40 mg O-phenylenediamine in 100 ml of 0.1 M phosphate citrate buffer (pH
5.0) activated immediately before use by adding 40 pi HoCT (30 % v/v).
2.8.6 Stopping solution
The stopping solution contained 12.5 % (v/v) H2SO4.
2.9 Monoclonal and polyclonal antibodies
Monoclonal and polyclonal antibodies, the animal from which they were obtained,
isotype and source are listed in Tables 2.1 and 2.2.
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Table 2.1 Monoclonal antibodies used to detect host cell antigens
Monoclonal antibody Host Isotype Source
Anti-Lewisa mouse IgM SAPU*
Anti-Lewis^ mouse IgM SAPU
Anti-LewisX (Anti-CD15) mouse IgM SAPU
Anti-CD 14 mouse IgG SAPU
Anti-CD 18 rat IgG Dako
Anti-H type 2 mouse IgM Serotec
* SAPU Scottish Antibody Production Unit
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Table 2.2 Polyclonal antibodies used to detect monoclonal antibodies
Polyclonal antibody Host Isotype Source
FITC anti-mouse rabbit IgM Sigma
FITC anti-mouse rabbit IgG Sigma
FITC anti-rat rabbit IgG Serotec
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Chapter 3
Effect of infection with subgroups A or B of RSV on binding
of bacteria associated with meningitis to a human epithelial
cell line (HEp-2)
3.1 Introduction
Three species account for the majority of cases of bacterial meningitis, N. meningitidis,
H. influenzae and S. pneumoniae (Salih, 1990). For epidemiological studies, these
bacteria have been classified based on their cell surface antigens, mainly their capsular
polysaccharides, which must be considered in studies on host-parasite interactions, as
particular antigenic types are associated with meningitis.
3.1.1 N. meningitidis
N. meningitidis is an encapsulated Gram-negative diplococcus with a flattened shape
and an average size of 0.6 x 0.8 pm. Three different groups of surface structures of the
meningococci have been used for strain differentiation : capsular polysaccharides (CPS);
outer membrane proteins (OMP); lipooligosaccharide (LOS). An extensive phenotypic
classification system has been developed on the basis of these surface components
(Table 3.1). Serogroups are based on differences in the structure of the CPS.
Serotypes and subtypes are based on differences in class 2/3 and class 1 OMP
respectively. Immunotypes are based on differences in the oligosaccharide structure of
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Table 3.1 Phenotypic classification system of N. meningitidis
category antigens no. of groups
or types
Serogroups CPS 12
Serotypes Class 2/3 OMP 20
Subtypes Class 1 OMP 10
Immunotypes LOS 12
CPS = capsular polysaccharide
OMP = outer membrane protein
LOS = lipooligosaccharide
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the meningococcal LOS (Frasch et al., 1985; Griffiss et al., 1988; Kim et al., 1988;
Peltola, 1983; Poolman et al., 1982; Tsai et al., 1987; Zollinger and Mandrell, 1980).
3.1.2 H. influenzae
H. influenzae produce a polysaccharide capsule which is used to classify this species
into six distinct antigenic types, designated a-f. The most important of these is type b
(Hib). In the UK prior to development of an effective vaccine for infants, more than
95% of all invasive diseases attributable to H. influenzae, including meningitis,
septicaemia, pneumonia, epiglottis, cellulitis, arthritis, osteomyelitis, and pericarditis,
were due to H. influenzae type b (Wilfert, 1990).
The majority of all systemic H. influenzae type b infections occurred in children younger
than 18 months of age. The peak incidence of meningitis and other invasive Hib
disease occurs in children 6 to 7 months of age. Children younger than 18 months of
age are more likely to have meningitis than other forms of invasive disease.
Epiglottitis, however, is more likely to occur in older children, with a peak occurrence
among 3 year olds (Wilfert, 1990).
There is seasonal variation in the incidence of H. influenzae type b infections. Unlike
the other major causes of bacterial meningitis (S. pneumoniae and N. meningitidis), the
peak incidence of which regularly occurs between January and March, there was a
bimodal pattern to the occurrence of H. influenzae type b meningitis with peaks in
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October-November and March-May (Ward et al., 1986; Ward and Cochi, 1988;
Broome, 1987).
3.1.3 S. pneumoniae
Pneumococci are the second most frequent cause after H. influenzae type b of bacterial
meningitis (Dagan et al., 1994) and otitis media (Musher, 1992) in children. The
incidence of pneumococcal disease is highest in infants under 2 years of age and in
people over 60 years of age (Garcia-Leoni et al., 1992; Gray et al., 1979). Because of
the introduction of conjugate vaccines for H. influenzae type b, pneumococcal
meningitis is likely to become increasingly prominent. In adults, S. pneumoniae is the
most important etiological agent of community-acquired pneumonia and is the second
most common cause of bacterial meningitis after N. meningitidis. In spite of the
availability of antibiotics, the mortality of pneumococcal disease remains high between
25 and 29% (Gillespie, 1989).
Pneumococci are classified on the basis of differences in capsular polysaccharide
structure into 90 serotypes. The Danish nomenclature classifies serotypes according to
structural and antigenic characteristics; e.g., serotypes 6A and 6B differ only slightly
from each other. The American nomenclature, assigns the numbers in sequence of first
isolation, so types 6A and 6B are types 6 and 26, respectively (Alonso DeVelasco et al.,
1995).
The distribution of types isolated from adults differs substantially from that of types
isolated from children. Serotypes 14, 6, 18, 19, 23, 1, 4, and 9 are associated with most
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of the serious infections in children; these types accounted for about 85 % of all
infections (Gray and Dillon, 1986; Jacobs et al, 1979). In adults, however, serotypes 1,
3, 4, 7, 8, 9, 12, 14, and less often 6, 18, and 19 as a group have been associated with
most serious bacteremic disease (Smart et al., 1987; Gray and Dillon, 1986; Jacobs et
al., 1979
3.1.4 Host cell receptors involved in enhancement of bacterial binding
by virus infection
Because the peak incidence of RSV infection coincides with the winter peak of bacterial
meningitis and is common among children in the age range at greatest risk, this virus
was used in a model system to assess the effect of the viral infection on binding
bacterial species that cause meningitis. There are two antigenically distinct types of
RSV, designated subgroups A and B based on variation in the attachment glycoprotein
G (Akerlind et al., 1988. Anderson et al., 1991; Cane et al., 1991). RSV-A infection of
HEp-2 cells was shown to enhance significantly binding of N. meningitidis and Hib
(Raza et al., 1993). Other work by this group demonstrated that other respiratory
pathogens followed a similar pattern in which binding to RSV infected cells was
significantly enhanced, S. aureus (Saadi et al., 1993) and B. pertussis (Saadi et al.,
1996).
There are two ways in which virus infection could enhance bacterial binding by altering
the cell surface: 1) production of virus encoded antigens that act as new receptors for
bacteria; 2) enhancement of native host cell receptors.
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Monoclonal antibodies (Mabs) generated against RSV distinguish the two subgroups (A
and B) according to epitope variations in the G proteins (Anderson et al., 1985; Mufson
et al., 1985). Variations in the G protein appear to be the most common, whereas the
other major surface protein (F) has relatively minor differences (Akerlind et al., 1988;
Anderson et al., 1985; Cane et al., 1991). The study by Raza and colleagues (1994)
was carried out with RSV subgroup A, and it was demonstrated that the glycoprotein G,
but not glycoprotein F, was an additional receptor for meningococci on RSV infected
cells.
Initial studies on host cell antigens of RSV-A infected cells indicated that CD14, CD15
and CD 18 were enhanced compared with uninfected cells. Pre-treatment with
monoclonal antibodies to CD 14 and CD 18 significantly reduced binding of
meningococci (Raza et al., 1994); however the effects of virus infection on binding of
Gram-positive bacteria were not examined.
3.1.5 Bacterial components involved in enhanced binding to RSV
infected cells
In the initial studies by Raza et al. (1993), meningococcal strains of different
serogroups, serotypes, and subtypes were examined. Differences in these antigenic
characteristics did not have an effect on the enhanced binding to RSV infected cells.
The effect of differences in LOS structures were not examined as immunotyping is not
routinely carried out even by most reference laboratories.
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Immunotypes L8, L9, L10, and LI 1 are found within group A meningococci; of these,
L10 and LI 1 are prevalent and are uniquely associated with this serogroup (Kim et al.,
1989; Salih et al., 1990; Zollinger and Mandrell, 1977). Immunotypes LI through L9
are identified within serogroups B and C meningococci. Studies by Zollinger and
Mandrell (1977) and Poolman and colleagues (1982) suggest that immunotype L3,7,9 is
the most prevalent within these serogroups, followed by immunotypes L2 and LI,8.
The distribution of LOS immunotypes among serogroup B meningococci might become
of special interest, because the LOS is a potential vaccine candidate (Poolman, 1990).
Although pili are expected to be involved in binding to epithelial cells (Virji et al.,
1992), the procedures used in the preparation of bacteria for the binding assays remove
these structures; therefore, they are not likely to be involved in the enhanced binding to
virus infected cells observed in previous studies.
3.1.6 Aims of the study
The aims of this part of the study were:
1) to determine if there is a similar pattern of enhanced binding of meningococci and H.
influenzae type b to RSV B infected cells as observed with RSV A;
2) to determine if there is increased binding of S. pneumoniae serotypes associated with
meningitis to RSV infected cells;
3) to assess the role of meningococcal oligosaccharide structures (immunotypes) in
binding to RSV infected cells;
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4) to compare the expression of host cell antigens that can act as receptors for bacteria
on uninfected and RSV-infected HEp-2 cells.
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3.2 Materials and methods
3.2.1 Cells
HEp-2 cells were used between passages 151-184 for the binding assays. HEp-2 cells
2
were grown for 24 hr in 75 cm flasks in GM (2.4.1). Monolayers of uninfected and
RSV-infected HEp-2 cells were maintained for an additional 24 hr in MM (2.4.2).
3.2.2 Viruses
RSV subgroup A (Edinburgh strain) (Ogilvie et al., 1981) and subgroup B (strain
18573) were used at passages 10-12 and 6-8 respectively to infect the HEp-2 cells.
Stock aliquots of supernatant fluid from infected cell lysates were stored at -70°C and
contained approximately lxlO6 plaque forming units (p.f.u) ml 1 as described in 2.3.1.
3.2.3 Bacteria
Strains of A. meningitidis were obtained from several sources: C:2b:P 1.2 was provided
by Dr. R. J. Fallon the Meningococcal Reference Laboratory, Ruchill Hospital,
Glasgow, Scotland; NG:2b:P1.10, and B:2b:P1.10 was obtained from Dr. G. Tzanakaki,
National School of Public Health, Athens, Greece. Twelve meningococcal
immunotype strains were provided by Dr. W. D. Zollinger, Walter Reed Army Medical
Institute, Washington DC, USA. One strain of Neisseria lactamica (LOl) was obtained
from Dr. H. Young of this department. Three strains of S. pneumoniae associated with
meningitis (types 7F, 12F, and 18C) were kindly provided by Dr. L. E. Smart, The
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Meningococcal and Pneumococcal Reference Laboratory, Stobhill Hospital, Glasgow,
Scotland. There was one strain of H. influenzae type b isolated from a local patient.
Bacterial cultures were prepared by reconstituting lyophilized strains in distilled water
and plating on appropriate media. N. meningitidis and N. lactamica were grown on
MNYC (Young, 1978). Pneumococci were grown on Columbia blood agar with horse
blood (BA). H. influenzae were grown on boiled blood agar (BBA). Each of the
strains were grown overnight at 37°C in a humidified atmosphere with 10% CO2,
harvested, washed three times in PBS by centrifugation at 2500 x g for 15 min and
resuspended in MM without antibiotics by vigorous pipetting to disperse clumps.
The bacterial concentrations were determined by measuring optical density (OD) at 540
nm. For each strain the linear relationship between OD reading and total count
assessed microscopically with a Thoma counting chamber was determined. A standard
curve was prepared for each strain used.
3.2.4 Infection of HEp-2 cells with RSV-subgroups A or B
3
Overnight monolayer cultures of HEp-2 cells in culture flasks (75cm ) were infected
with RSV-subgroups A or B at a multiplicity of infection (MOI) of 1.0 p.f.u / cell.
Virus (2.5ml in MM) was adsorbed for 1 hr, the fluid was replaced with 25 ml MM and
incubated overnight at 37°C. Cultures were rinsed twice with sterile DPBS+A and
harvested by adding 5ml of 0.05% ethylenediaminetetraacetic acid (EDTA) per flask at
37°C for 5-10 min. MM (5ml) was added to the cells to counteract EDTA activity.
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The cells were centrifuged at 460 x g for 7 min and resuspended in MM without
antibiotics, counted and adjusted to lxlO6 cells ml"1 (Raza et al., 1993).
3.2.5 Bacterial binding to RSV-infected HEp-2 cells
The bacterial suspensions were labelled with FITC (Sigma) freshly prepared as a 0.4 %
(w/v) solution in NaFbCC^ (0.05M) and NaCl (0.1M) (pH 9.2). The washed bacterial
pellet obtained from two culture plates was suspended in 2 ml of the FITC solution by
gentle shaking and incubated at 37°C for 30 min (Raza et al., 1993). FITC-labelled
bacteria were washed three times in PBS and resuspended in MM without antibiotics.
The concentration of the suspension was determined by OD at 540 nm and adjusted to
provide a range of ratios of bacteria per cell (Raza et al., 1993).
The bacterial suspensions (200 pi) were incubated with equal volumes of uninfected
HEp-2 cells, or HEp-2 cells infected with RSV-A or RSV-B at 37°C in an orbital
incubator (Gallenkamp) for 30 min at 60 rpm. The cells were washed three times at
460 x g with PBS, resuspended in 200 pi of PBS and fixed with 100 pi of 1% buffered
paraformaldehyde and stored in the dark at 4°C until analysed by flow cytometry within
48 hours of preparation.
3.2.6 Detection of RSV infected cells
3.2.6.1 Fluorescence microscopy
Coverslips with monolayers of HEp-2 cells were prepared
subgroups A or B at a MOI of 1.0 following incubation for
/ "
I ft'
and infected with RSV
16-24 hr, the cells were
fixed. The coverslips were incubated with 10 |il of the direct immunofluorescence
reagent as described in (2.6.1). For each coverslip, 100 cells were counted.
3.2.7 Flow cytometry
Flow cytometry is capable of analysing and sorting single cells with great speed and
efficiency in their natural form. The major components of the EPICS-XL (Coulter
Electronics, Luton, UK) include: (1) flow cell into which a stream of labelled cells was
injected; (2) a laser light source (15 mW argon ion laser at 488 nm) to excite
fluorescence of the cells in the stream formed by the flow system; (3) photomultiplier
tube system to measure the emitted fluorescence as well as to determine the degree of
laser light scattered by each cell; (4) a mechanism for placing a given cell into a droplet
which can be separated from other droplets on the basis of the fluorescence, size, and
viability characteristics of the cell; (5) a computer system for the analysis and storage of
data (Figure 3.1).
3.2.7.1 The principles of flow cytometry
The flow cytometry measures the light scatter of cells as they passed one by one through
a laser bean. Cells scatter the laser light at low-angle in the forward direction according
to their size; small cells scatter small amounts of light and large cells scatter greater
amounts of light. Cellular granularity is directly proportional to the amount of laser
light scattered at a 90° angle (also referred to a side scatter). Data are displayed
graphically by plotting forward versus side scatter to produce a two parameter histogram
or scattergram (Fig 3.2a). The instrument electronically selects the desired cell
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Dichroic mirrors
Figure3.1Thmajorcomp nentsfthflowcytometry, (adaptedfromClinicalImmunology,CatherineS ehan,1997)
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Figure 3.2 Flow cytometric analysis showed population of interest (the bitmap) (A),
control cells with no bacteria (B), and FITC-conjugated bacteria attached (C).
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population for analysis by drawing a gate or window around the population of interest
(the bitmap) (Fig 3.2a).
In addition to detectors for forward angle scatter and side scatter, there are detectors to
measure the fluorescence emitted from labelled bacteria attached to cells. These data
are displayed as a single parameter histogram that plots the number of cells versus
fluorescence (Fig 3.2c). Cells with no bacteria or cells with FITC-conjugated
secondary antibody were analysed first to establish background fluorescence. Figures
3.2b and 3.2c are examples for the control and test samples respectively from a single
experiment.
For each sample analysed, two parameters were obtained: 1) the percentage of cells in
the population that showed fluorescence levels higher than the background (cells
incubated without FITC-labelled bacteria); 2) the mean levels of fluorescence in the
population of cells with bound bacteria reflecting the mean number of bacteria bound
per cell on a logarithmic scale. The mean fluorescence channel values for positive cells
were obtained from a conversion table of log fluorescence supplied by the manufacturer
(Coulter). Some individuals cells showed bound FITC-conjugated secondary antibody
(control). A computer programme (Immunoanalysis, Coulter) was applied to
recalculate the percentage and the mean of the test by assessing overlap of the two
histograms (control and test) (Figure 3.3).
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Figure 3.3 Examples of immunoanalysis of the control, test, and overlap of the two
histograms.
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3.2.7.2 Calculation of binding index (BI)
A binding index for each sample in the study was calculated by multiplying the
percentage of positive cells and the mean fluorescence of positive cells. It has been
suggested that mean numbers of bacteria attached to whole population of cells provide a
move accurate estimate of adhesiveness. In this study the data were presented as
binding indices, since the virus infection might affect the percentage of cells binding
bacteria and the mean numbers of bacteria bound.
3.2.8 The effect of FITC on bacterial binding
HEp-2 cells (lxlO5 ml ]) in GM were seeded on to glass coverslips (1ml / well) in 24
well culture plates (Costar) and incubated in 5% CCE in air overnight at 37°C. The
GM was removed and 200 pi of FITC-labelled or unlabelled bacteria (200 bacteria :
cell) were added to the coverslips for 30 min at 37°C in an orbital incubator. The
coverslips were washed three times with PBS, fixed in absolute ethyl alcohol for five
minutes at room temperature, stained by Gram's stain and examined by light
microscopy with an oil immersion lens. The number of cells counted, number of cells
binding bacteria and number of bacteria per positive cell were recorded. For each
coverslip, 100 cells were counted. BI for each coverslip was obtained by multiplying
the proportion of cells which bound bacteria by the mean number of bacteria per
positive cell.
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3.2.9 Detection of host cell surface antigens on HEp-2 cells infected
with RSV-subgroups A or B
HEp-2 cells and HEp-2 cells infected with RSV-A or RSV-B (200 pi, lxlO6 ml-1) were
incubated for 60 min at 37°C with the following antibodies to the host cell surface
antigens listed in tables 2.1 and 2.2: CD 14 (1/2); CD 18 (1/20) and CD 15 (1/10). The
cells were washed twice with PBS and incubated for 30 min in an orbital shaker at 37°C
with FITC-labelled secondary antibodies used to detect binding of their respective
primary antibody: rabbit anti-mouse IgM (Sigma) diluted 1 in 100 in PBS; rabbit anti-
mouse IgG (Sigma) diluted 1 in 200 in PBS; or rabbit anti-rat IgG (Serotec) diluted 1 in
100 in PBS. The FITC-labelled second antibodies were incubated with the cells which
were not exposed to the primary antibody to control for non-specific binding.
Fluorescence was analysed with an EPICS 'XF' flow cytometer (Coulter, UK), and the
BI was calculated from the percentage of the cells with fluorescence greater than the
background (cells treated only with the FITC-labelled second antibody) multiplied by
the mean fluorescence for the positive population.
3.2.10 Inhibition of bacterial binding by antibodies to host cell
antigens.
Sources of monoclonal antibodies binding to cell surface antigens are listed in Table
2.1. RSV-A infected HEp-2 cells (200 pi) were incubated with PBS, mouse
monoclonal antibody to CD 14 diluted 1 in 2; rat monoclonal antibody to CD 18 diluted 1
58
X
in 20; Lewis (CD 15) diluted 1 in 10, RSV monoclonal anti-glycoprotein G diluted 1 in
100 (Prof. P. J. Watt, Southampton University) at 37°C for 60 min. After washing
twice by centrifugation at 300 x g for 10 min, the attachment assay with FITC-labelled
bacteria were performed and analysed as described in (3.2.7).
3.2.11 Statistical methods.
The data were assessed by estimate of relative binding of the bacteria to RSV-infected
HEp-2 cells compared with uninfected cells based on paired t-tests applied to logarithms
of the binding indices.
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3.3 Results
3.3.1 Determination of total bacterial count in relation to OD
For each strain, the bacterial concentration was determined by OD at 540 nm and in
relation to total count obtained by light microscopy with a Thoma counting chamber.
Graphs of the range of readings of OD values having a linear relationship with the total
counts were prepared for each of the isolates: N. meningitidis (Figure 3.4); H. influenzae
type b (Figure 3.5); N. lactamica (Figure 3.6); S. pneumoniae (Figure 3.7) and N.
meningitidis LOS immunotype strains (Figure 3.8).
3.3.2 The effect of FITC on bacterial binding:
To examine the effect of FITC on binding of the bacteria to HEp-2 cells, binding of all
the strains, FITC-labelled and unlabelled, were examined by light microscopy. Binding
of each strain was tested twice for binding to monolayers of HEp-2 cells and the
averages of the two experiments are summarised in (Tables 3.2 and 3.3). At a ratio of
200 bacteria : cell, there were no significant differences in BI of FITC-labelled bacteria
compared with unlabelled bacteria.
3.3.3 Determination of binding to HEp-2 cells
Dose response experiments were carried out with HEp-2 cells for each strain: N.
meningitidis and N. lactamica (Figure 3.9); S. pneumoniae isolates associated with























Figure 3.4 Total bacterial count (x 10 ) determined by microscopy versus optical density

























Figure 3.7 Total bacterial count (x 10 ) determined by microscopy versus OD of S.
pneumoniae serotypes associated with meningitis.
64
Optical Density
Figure 3.8 Total bacterial count (x 10 ) determined by microscopy versus OD of N.
meningitidis LOS immunotype strains.
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Table 3.2 Comparison of binding indices of FITC-labelled and unlabelled
bacteria to HEp-2 cells assessed by light microscopy (200 bacteria :
cell).
Species Strain non-labelled FITC-labelled
N. meningitidis C:2b:P1.2 421 378
NG:2b:P1.10 501 460
B:2b:P1.10 485 429
H. influenzae type b 582 515
N. lactamica LOl 475 424
S. pneumoniae* 7F 494 481
12F 450 432
18C 448 387
(*) Strains associated with meningitis
66
Table 3.3 Comparison of binding indices of labelled and unlabelled N.
meningitidis LOS immunotype strains to HEp-2 cells assessed by
light microscopy (200 bacteria : cell).
Species Strain non-labelled FITC-labelled
















Figure 3.9 Representative dose response curves obtained with 3 N. meningitidis isolates























Figure 3.10 Representative dose response curves obtained with 3 S. pneumoniae
serotypes associated with meningitis.
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Bacteria: cell
Figure 3.11 Representative dose response curves obtained with 4 N. meningitidis LOS
immunotype strains.
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and H. influenzae type b (Figure 3.12). The results for the isolates of each species were
similar. The binding of the non-capsulate N. lactamica was higher than that observed
for the capsulate meningococci (Figure 3.9). For experiments in which binding of
bacteria to RSV-infected and uninfected HEp-2 cells was assessed, a ratio of bacteria :
cell at the midpoint of the dose response curve was used.
3.3.4 Attachment of Gram-negative species to RSV infected cells:
Table 3.4 summarises the results of 6 experiments in which a ratio of 200 bacteria : cell
was used to assess the effect of infection with RSV-A or RSV-B on binding to HEp-2
cells by N. meningitidis, H. influenzae, and N. lactamica. All the bacterial species
showed enhanced binding to cells infected with RSV-A or RSV-B compared to
uninfected cells. For each strain binding was greater to cells infected with RSV-A;
however, except for the N. lactamica isolate (P < 0.01), the experiments showed no
significant differences between RSV-A and RSV-B in binding to N. meningitidis, or H.
influenzae (Table 3.5).
3.3.5 Attachment of S. pneumoniae strains to RSV-infected HEp-2
cells.
At a ratio of 200 bacteria : cell, the three serotypes of S. pneumoniae associated with
meningitis had significantly greater binding indices to HEp-2 cells infected with either
RSV-A or RSV-B compared with their binding indices for uninfected HEp-2 cells. The
results for six assays with S. pneumoniae were combined for analysis (Table 3.6).
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Bacteria : cell
Figure 3.12 Representative dose response curves obtained with H. influenzae type b.
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Table 3.5 The differences in binding of RSV-A or RSV-B infected HEp-2
cells with Gram-negative species
Species Strain 95% CI for RSV-A
as % of RSV-B
P
N. meningitidis C:2b:P1.2 83-166 NS
NG:2b:P1.10 81-139 NS
B:2b:Pl. 10 75-195 NS
H. influenzae type b 93-199 NS
N. lactamica LOl 129-203 0.01
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Although the binding indices were greater for RSV-A infected cells, there was no
significant difference between cells infected with RSV-A or RSV-B in binding of S.
pneumoniae (Table 3.7).
3.3.6 Attachment of N. meningitidis LOS immunotype strains to RSV-
infected HEp-2 cells.
Table 3.8 summarises the results of 6 experiments in which a ratio of 400 bacteria : cell
was used to assess the binding of strains with different LOS immunotype antigens to
virus infected cells. Each of the 12 immunotype strains exhibited enhanced binding to
HEp-2 cells infected with RSV-A or RSV-B compared to uninfected HEp-2 cells.
Table 3.9 summarises the differences between RSV-A or RSV-B infected cells in
binding of the 12 immunotype strains tested; 8 bound in significantly greater numbers to
RSV-B infected cells.
3.3.7 Detection of host cell surface antigens on HEp-2 cells infected
with RSV-subgroups A or B
Table 3.10 summarises the results of 4 experiments in which binding indices for
monoclonal antibodies directed toward cell surface antigens indicate there was no
significant difference in binding of anti-CD 15 to HEp-2 cells or HEp-2 cells infected
with RSV-subgroups A or B. There were significant increases in binding of anti-CD 14
(P < 0.001) and anti-CD 18 (P < 0.001) to HEp-2 cells infected with RSV-A, the same
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Table 3.7 The differences in binding of RSV-A or RSV-B infected HEp-2 cells
with S. pneumoniae associated with meningitis
Species strain 95% CI for RSV-A
as % of RSV-B
P

































































































































Table 3.9 The differences in binding of HEp-2 cells infected with RSV-A or RSV-B
with N. meningitidis LOS immunotype strains
strain phenotype RSV-A as % of RSV-B
(95% CI)
P
LI C : NT : P1.2 LI,8 88 (81-96) 0.05
L2 C : 2C : Pl.l L2 89 (82-95) 0.01
L3 B : 2a: Pl.5,2 L (3,7),7 94 (87-101) NS
L4 C : 11 : PI. 16 L4 92 (85-99) 0.05
L5 B:4:NT L5 92 (82-102) NS
L6 B : 5 : Pl.7,1 L6,7 92 (86-99) 0.05
L7 B : 9 : PI.7,1 L(3,7),7 91 (84-98) 0.05
L8 B : 8,19 : Pl.7,1 L(3,7),7,8 94 (89-100) NS
L9 A : 21 : P1.10 L (3,7),7 92 (82-102) NS
L10 A: L10 90 (86-93) 0.05
LI 1 A : 21 : P1.10 LI 1 91 (84-99) 0.05
L12 A : 21 : NT L12 86 (79-94) 0.01
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Table 3.10 Binding indices for monoclonal antibodies to host cell surface antigens on
HEp-2 cells and RSV-subgroups A or B infected HEp-2 cells
Antibodies mean BI of uninfected
HEp-2 cells
mean BI of RSV-A
infected cells
mean BI of RSV-B
infected cells
P
CD 14 1549 6885 7008 0.001
CD 18 3629 8640 8594 0.001
CD 15 1587 1565 1517 NS
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pattern was observed with the RSV-B infected HEp-2 cells anti-CD 14 (P < 0.001) and
Anti-CD 18 (P < 0.001) compared with uninfected HEp-2 cells.
3.3.8 Inhibition of binding of S. pneumoniae by treatment of
HEp-2 cells with monoclonal antibodies
3.3.8.1 Host cell antigens
Previous work in this laboratory found that binding of meningococci to HEp-2 cells and
HEp-2 cells infected with RSV-A could be inhibited by pre-treatment of the cells with
monoclonal antibody to CD 14 or CD 18 (Raza et al., 1994). These studies were
repeated with Gram positive strains.
In four experiments, pre-treatment of RSV-A infected HEp-2 cells with monoclonal
antibody to CD 14, CD 18 or CD 15 did not significantly reduce binding of pneumococcal
strain 12F: anti-CD 14 (95% CI 96-112); anti-CD 18 (95% CI 101-106); and anti-CD 15
(95% CI 99-102) (Figure 3.13). The same pattern were observed with the strain 18C:
anti-CD 14 (95% CI 98-101); anti-CD18 (95% CI 96-105); and anti-CD15 (95% CI 95-
106) (Figure 3.14).
3.3.8.2 Glycoprotein G of RSV
Data from 4 experiments indicated that monoclonal anti-glycoprotein G bound to the
viral glycoprotein G on the surface of infected cells (Figure 3.15), but there was no
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Figure 3.15 Binding of monoclonal antibody to RSV glycoprotein G with HEp-2 cells
RSV infected HEp-2 cells.
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Pre-treatment of HEp-2 cells or RSV-A infected HEp-2 cells with the monoclonal
antibody had no effect on binding of either pneumococcal isolate tested (Table 3.11).
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Table3.11heffectofpre-tr atmentHEp-2cellsandRSV-inf ct dwi hmo oclonalant bo ytglycoproteinG ofRSVnbindingfS.pneumoniaespecies. AntibodyStrainmeanBIof uninfected cellsmeanBIof uninfected cellswithanti-GmeanBIof RSV-infected cellsmeanBIofRSV- infectedcells withanti-G95%CIfortreated uninfectedcells withanti-Gs% ofuninfectedcells





















The results provided evidence to answer the questions posed in the introduction.
Variations in glycoprotein (G) between RSV subgroups A and B had been reported
(Akerlind et al., 1988; Anderson et al., 1991; Cane et al., 1991), and previous work by
our group demonstrated that glycoprotein G of RSV-A was an additional receptor for
meningococci (Raza et al., 1994). This study demonstrated that infection of HEp-2
cells with RSV-B also enhanced bacterial binding. Initial studies showed there were
higher levels of binding observed on cells infected with subgroup A compared with
subgroup B (Table 3.4).
There was significantly enhanced binding of meningococci, Hib, N. lactamica, and S.
pneumoniae strains associated with meningitis to cells infected with either RSV-A or
RSV-B in experiments in which both subgroups of the virus were tested at the same
time. The N. lactamica isolate bound more to RSV-A infected cells (Tables 3.5; and
3.7) and some meningococcal immunotype strains bound more to RSV-B infected cells
(Table 3.9); however, for most strains, statistical analysis showed no significant of
differences in binding to cells infected with RSV-A or RSV-B.
Previous studies indicated that enhanced binding of N. meningitidis strains was not
associated with particular serogroup (capsular), serotype (outer membrane protein 2/3)
or subtypes (outer membrane protein 1) antigens on the bacteria (Raza et al., 1993).
Strains with different LOS immunotype antigens were assessed for binding to determine
if the carbohydrate composition of the endotoxin affected binding to virus infected cells.
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Each of 12 immunotype strains exhibited enhanced binding to HEp-2 cells infected with
RSV-A or RSV-B compared to uninfected ElEp-2 cells. With the exception of strains
L4, L5, L8 and L9, the results showed that cells infected with the RSV subgroup B
bound significantly more bacteria than those observed with RSV-A infected cells.
Previous work in this laboratory found RSV infected cells show increased binding of
monoclonal antibodies to CD 14, CD 15 and CD 18 (Raza et al., 1994b). Pre-treatment
of uninfected or RSV infected HEp-2 cells with monoclonal antibodies to CD 14 and
CD 18 significantly reduced binding of meningococci (Raza et al., 1994). This was not
observed with the Gram-positive pneumococcal strains tested. This indicates that the
enhanced binding of Gram-negative bacteria to RSV infected cells is partly due to
enhanced expression of host cell components that bind endotoxin (Wright and Jong,
1986). Glycoprotein G of subgroup A has been shown to be an additional receptor for
meningococci (Raza et al., 1994a), but pre-treatment of HEp-2 cells or RSV-A infected
HEp-2 cells with the monoclonal to glycoprotein G did not affect binding of the 2
pneumococcal strains. These results indicate that the changes in host cell antigens that
enhanced binding of meningococci are not the same as those that enhance binding of
pneumococci.
Colonisation of the upper respiratory tract with H. influenzae, S. pneumoniae, or N.
meningitidis is thought to be the initial event in the pathogenesis of bacterial meningitis.
The majority of children with bacterial meningitis had signs and symptoms of upper
respiratory infection, suggesting that viral infection promotes bacterial spread and
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invasion (Krasinski et al., 1987). This study showed enhanced binding of species that
cause meningitis to RSV A or RSV B infected cells might contribute to density of
colonisation which is associated with development of disease (Beachey, 1981).
An epidemiological study published after this work began found no strong correlation
between outbreaks of meningococcal disease and RSV infection (Stuart et al., 1996).
Screening of patients with meningococcal infection for evidence of RSV infection,
either identification of the virus or serological response, is needed to determine if
infection by these viruses plays a significant role in susceptibility to meningitis. There
is, however, good evidence that RSV predisposes children to respiratory infection;




The effect of infection with RSV A or RSV B on binding of
bacteria associated with respiratory tract infection to
HEp-2 cells
4.1 Introduction
S. pneumoniae, non-typable H. influenzae and M. catarrhalis are the three species most
commonly associated with bacterial respiratory tract infection in both children and
adults. These species are also isolated from children with acute otitis media (AOM)
and adults with acute exacerbation of chronic bronchitis and chronic obstructive
pulmonary disease (COPD).
4.1.1 Infection in children
The infection of the respiratory tract by viruses and subsequent bacterial colonisation
and infection, for instance bacterial pneumonia associated with measles or influenza, are
potentially fatal problems. RSV was chosen for these studies because it is recognised
as an important viral respiratory pathogen in infants and in young children causing
bronchiolitis and pneumonia. It is a major cause of hospitalisation in infants less than
six months of age and secondary bacterial infections such as acute otitis media and
pneumonia are common (Ruuskanen and Ogra, 1993). In a Finnish study, RSV
infections were associated with a significant rise of antibodies to H. influenzae, M.
catarrhalis and pneumococcal antigens (Korppi et al., 1989). A recent study of
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invasive pneumococcal disease was associated with RSV infection in both adults and
children (Kim et al., 1996).
Several studies have indicated a crucial role of respiratory viruses in the pathogenesis of
AOM which is the most common respiratory tract infection of infancy and early
childhood (Klein, 1994). Increased rates of AOM have been noted especially during
epidemics of RSV, influenza A virus and rhinovirus (Ruuskanen et al., 1991).
Bacterial pathogens isolated from approximately two thirds of children with AOM are S.
pneumoniae followed by non-typable strains of H. influenzae and M. catarrhalis.
A high frequency of mixed viral and bacterial infections has been documented in
developing countries. In Papua New Guinea two-thirds of documented viral infections
occurred concurrently with a bacterial infection (Shann et al., 1984). In Pakistan, 26%
of children infected with RSV also had bacteraemic infection with Haemophilus species
or S. pneumoniae (Ghafoor et al., 1990). Fifty-four percent of the cases of bactereamic
Haemophilus infection and 47% of bacteraemic infection with S. pneumoniae were
associated with viral infection (Berman, 1991).
In the United States simultaneous infections with RSV and B. pertussis have been
demonstrated. In one study of 29 children with pertussis, 14 also had RSV infection
(Nelson et al., 1986). The temporal sequence of these two infections could not be
determined. The symptoms and signs of RSV infection or pertussis alone were similar.
91
4.1.2 Infection in adults
RSV is a significant cause of serious lower respiratory tract infection in
immunocompromised adults and the elderly (Falsey et al., 1995). In a family study,
17% of the adults living with infected children also became infected (Hall et al., 1976).
In adults, RSV infection can be asymptomatic or can induce mild to moderate upper
respiratory tract symptoms. In healthy adults, the infection is rarely severe or fatal
(Aylward and Burdge, 1991). The average duration of virus shedding is 5 days (Hall et
al., 1991). Based on clinical features, RSV infection cannot be differentiated from the
common cold induced by other etiologic agents.
4.1.2.1 Pneumonia
Pneumonia due to either bacterial or non-bacterial causes is characterised by prolonged
respiratory symptoms and persistently abnormal chest X ray (Kirtland and Winterbauer,
1991). Prior infection by respiratory viruses has long been regarded as one factor that
predisposes to pneumococcal pneumonia. Studies have shown the rate of
nasopharyngeal colonisation by S. pneumoniae to be greatest in autumn, winter, and
early spring among families, adults in a closed environment (such as military recruits),
and in the population at large (Gray et al., 1982). The observed association between
season and pneumococcal carriage or pneumococcal infection might be mediated
through the seasonal incidence of viral illness.
The study by Kim and colleagues (1996) using the novel approach of a community-
based viral surveillance system found a distinct temporal association between invasive
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pneumococcal disease in adults and viral-type respiratory illnesses of all kinds. They
also found that pneumococcal disease was associated with isolation of RSV.
4.1.2.2 Acute exacerbation of chronic bronchitis (AECB)
By definition, chronic bronchitis is the production of sputum on most days of 3
consecutive months in at least 2 consecutive years (Wilson, 1995). Manifestations of
acute bacterial exacerbations are predominantly bronchopulmonary and include greater
frequency and severity of cough, increased sputum production, purulent sputum,
haemoptysis, chest congestion and discomfort, and increased dyspnea and wheezing.
Many micro-organisms have been associated with exacerbations of chronic bronchitis,
however, the predominant pathogen is non-typable H. influenzae which has been
recognised to cause more than 50 % of all bacteriologically defined exacerbations (Ball,
1995). The proportions of major bacterial respiratory pathogens isolated from patients
in clinical trials indicated that M. catarrhalis and S. pneumoniae account for
approximately a further third of isolates from AECB (Chodosh, 1992). These bacteria
are persistently present in respiratory secretions of established chronic bronchitic
patients. If, as suggested by Beachey (1981), density of colonisation is a major
determinant for disease, factors that enhance the bacterial load might contributes to
exacerbation of symptoms among these patients.
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4.1.2.3 Chronic obstructive pulmonary disease (COPD)
COPD is characterised by periodic exacerbation in which the patient experiences
worsening of symptoms, including increased cough and sputum production, increased
sputum purulence and shortness of breath. Infection was the most common observable
cause of death in a prospective study of patients with COPD (Burrows and Earle, 1969).
The role of bacterial infection in COPD has been the subject of intense investigation
over the past 40 years (Murphy and Sethi, 1992).
Bacteria may be involved in the pathogenesis of exacerbations in two ways. They
could be the primary cause of the exacerbation; alternatively, they could act as
secondary invaders after acute viral or mycoplasmal infection. Studies using viral
cultures and serologic assays have established that viral and to a lesser extent,
mycoplasmal infections cause approximately one third of these exacerbations (Buscho et
al., 1978; Tager and Speizer, 1975). Many studies have identified S. pneumoniae and
nontypable H. influenzae with purulent sputum and exacerbations of COPD (Tager and
Speizer, 1975; Murphy and Apicella, 1987). In addition, M. catarrhalis has emerged as
a pathogen in this setting (Doern,1986; Verghese et al., 1990).
4.1.3 Aim of the study
In the present study, the hypothesis tested was that HEp-2 cells infected with RSV
subgroups A or B might exhibit enhanced binding of the bacteria associated with
respiratory infections or exacerbation of chronic bronchitis.
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4.2 Materials and methods
4.2.1 Cells (3.2.1)
4.2.2 Growth of RSV viruses (3.2.2)
4.2.3 Bacteria
Five isolates of S. pneumoniae (types 42, 23, 10, 6, and 33) were obtained from
respiratory specimens by the Clinical Bacteriology Diagnostic laboratory, Department of
Medical Microbiology. Two isolates of M. catarrhalis (MCI and MC2) were obtained
from Dr. H. Young, Department of Medical Microbiology, Edinburgh University; MCI
grew on Modified New York City Medium (MNYC) and MC2 did not grow on this
medium which contained selective antibiotics. Two B. pertussis strains, 8002
(fimbriate, type 1,2) and 250815 (non-fimbriate, type 1,3), were supplied by Dr. N. W.
Preston, Department of Microbiology, University of Manchester.
S. aureus strain NCTC 10655 was obtained from The National Type Culture Collection.
Two non-typable H. influenzae isolates were obtained from throat cultures of infants
(Infection and Immunity Laboratory).
Pneumococci were grown on Columbia blood agar with horse blood (BA). The MCI
isolate was grown on MNYC (Young, 1978), the antibiotic-sensitive isolate (MC2) and
non-typable H. influenzae were grown on boiled blood agar (BBA). B. pertussis was
grown on charcoal agar (Difco, UK). S. aureus was cultured on nutrient agar. Except
for B. pertussis which required 3-5 days incubation, each strain was grown overnight at
37°C in a humidified atmosphere with 10% CCB. The bacteria were harvested, washed
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three times in phosphate buffered saline (PBS) by centrifugation at 2500 x g for 15 min
and resuspended in MM without antibiotics by vigorous pipetting to disperse clumps.
The bacterial concentrations were determined by measuring OD at 540 nm. For each
strain the linear relationship between OD reading and total count assessed
microscopically with a Thoma counting chamber was determined, and a standard curve
was prepared for each strain used.
4.2.4 Infection of HEp-2 cells with RSV-subgroups A or B (3.2.4)
4.2.5 Bacterial Binding to RSV-infected HEp-2 cells (3.2.5)
4.2.6 Detection of RSV-infected cells (3.2.6)
4.2.6.1 Fluorescence microscopy (3.2.6.1)
4.2.7 Flow cytometry (3.2.7)




4.3.1 Determination of total count in relation to OD
For each isolate, the bacterial concentration was determined by OD at 540 nm in relation
to the total count obtained by light microscopy with a Thoma counting chamber. The
range of OD readings providing a linear relationship with the total counts were used as
standard curves: S. pneumoniae, respiratory isolates (Figure 4.1); H. influenzae (non-
typable) isolates (Figure 4.2); M. catarrhalis (Figure 4.3); S. aureus (Figure 4.4); and B.
pertussis (Figure 4.5). The bacterial suspensions were adjusted to provide a range of
ratios of bacteria per cell for use in the assays.
4.3.2 The effect of FITC on bacterial binding
The effect of FITC on bacterial binding was examined by light microscopy with each of
the FITC-labelled and unlabelled bacterial species used in this study. The results in
Table 4.1 in which a ratio of 200 bacteria : cell (except for M. catarrhalis 400 bacteria :
cell and B. pertussis 500 bacteria : cell) was tested represent the mean of 2 experiment.
There were no differences observed in binding indices of FITC-labelled bacteria
compared with unlabelled bacteria.
4.3.3 Determination of bacterial binding to uninfected cells
Dose response experiments were carried out with HEp-2 cells for each strain: S.
pneumoniae respiratory isolates (Figure 4.6); H. influenzae non-typable isolates (Figure
4.7); M. catarrhalis (Figure 4.8); S. aureus (Figure 4.9); and B. pertussis
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Figure 4.4 Total bacterial count (x 10 ) determined by microscopy versus OD of S.




Figure 4.5 Total bacterial count (x 10 ) determined by microscopy versus OD of 5.
pertussis strains.
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Table 4.1 Comparison of binding indices of FITC-labelled and
unlabelled bacteria to HEp-2 cells assessed by light
microscopy.
Species Strain non-labelled FITC-labelled
M. catarrhalis MCI 546 507
MC2 539 499
H. influenzae 87D 409 396
(nontypable)
241D 431 401
B. pertussis type 1,2 397 387
type 1,3 412 369
S. pneumoniae * type 6 489 472
type 10 501 469
type 23 531 502
type 33 490 476
type 42 526 494




























Figure 4.8 Representative dose response curves obtained with 2 M. catarrhalis isolates.
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Bacteria: cell
Figure 4.9 Representative dose response curves obtained with S. aureus strain NCTC
10655.
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(Figure 4.10). For experiments in which binding of bacteria to RSV infected and
uninfected HEp-2 cells was assessed, a ratio of bacteria : cell at the mid point of the
dose response curve of the test strain was used.
4.3.4 Binding of Gram-negative bacteria to RSV-infected
HEp-2 cells
Table 4.2 summarises the results of 6 experiments in which the effect of infection with
RSV subgroups A or B on binding ofM. catarrhalis (400 bacteria : cell), non-typable H.
influenzae (200 bacteria : cell), and B. pertussis (500 bacteria : cell) to FlEp-2 cells was
assessed. Except for M. catarrhalis (MC2) which bound in significantly lower levels to
HEp-2 cells infected with either RSV-A or RSV-B, all the bacterial species showed
significantly enhanced binding to cells infected with RSV subgroups A or B. For non-
typable H. influenzae and B. pertussis, the binding to RSV-A infected cells was
significantly greater than to RSV-B infected cells (Table 4.3).
4.3.5 Binding of Gram-positive species to RSV infected HEp-2 cells
In 6 experiments, all the serotypes of S. pneumoniae isolated from patients with
respiratory infections and the S. aureus isolate demonstrated significantly greater
binding indices to HEp-2 cells infected with either RSV subgroups A or B compared
with their binding indices for uninfected HEp-2 cells (Table 4.4). For S. pneumoniae
strains there was no significant difference in binding to the RSV A-infected
108
Binding indices
Figure 4.10 Representative dose response curves obtained with 2 B. pertussis strains.
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Table 4.3 The differences between RSV-A and RSV-B on binding with
Gram-negative species
species isolate / strain RSV-A as % of RSV-B
(95% CI)
P
M. catarrhalis MCI 130 (97-174) NS
MC2 186 (86-390) NS
H. influenzae (NT) 87D 112(110-114) 0.001
24 ID 116(113-121) 0.001
B. pertussis type 1,2 110(105-115) 0.01
type 1,3 107 (100-114) NS
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cells compared with RSV-B infected cells; however, S. aureus bound in significantly
greater numbers to the RSV-A infected cells (Table 4.5).
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Table 4.5 The differences between RSV-A and RSV-B on binding with Gram-positive
species
species strain RSV-A as % of RSV-B
(95% CI)
P
S. pneumoniae type 6 96 (88-105) NS
type 10 100 (88-105) NS
type 23 104(101-106) 0.01
type 33 102 (89-117) NS
type 42 102 (96-108) NS
S. aureus NCTC 10655 112(102-122) 0.05
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4.4 Discussion
There is extensive evidence that virus infections are predisposing factors for bacterial
disease or carriage of respiratory pathogens. Most information has come from studies
of influenza virus and bacteria causing pneumonia such as pneumococci and
staphylococci. While RSV is primarily a cause of infection in children, recent studies
indicate it is an important predisposing factor for bacterial respiratory disease in older
age groups (Kim et al., 1996). The objective of this part of the study was to test the
hypothesis that HEp-2 cells infected with RSV-A or RSV-B would bind greater
numbers of bacteria associated with secondary respiratory infection or exacerbation of
chronic respiratory conditions. With the exception of the isolate MC2 of M.
ccitarrhalis, the results showed enhanced binding of each of the bacterial species tested.
As with pneumococcal serotypes associated with meningitis, differences in capsular
antigens of strains associated with respiratory infections did not affect the enhanced
binding to RSV infected cells. If there were significant differences in binding of these
bacteria to cells infected with the two subgroups, RSV-A infected cells were observed to
have higher binding indices (Tables 4.3 and 4.5).
There are many epidemiological studies of subgroups A and B RSV infections in the
United States and other countries. Monto and Ohmit (1990) showed that the two RSV
subgroups existed in one community since at least 1965. In almost all epidemics,
subgroups A and B have been found. The occurrence of outbreaks with predominantly
subgroup A or predominantly subgroup B varied according to the year and country
studied (Mcintosh et al., 1993). Many studies showed that different groups can
1 15
predominate in different geographic locations during the same year. A study from 14
laboratories in United States and Canada found 63% of 483 RSV isolates to be within
subgroup A and 24% within subgroup B (Anderson et al., 1991).
The identification of the two groups has led to the speculation that there might be a
relationship between severity of infection and RSV subgroup. McConnochie and
colleagues (1990) reported that subgroup A infections were more severe. Hall and
colleagues (1990) found in a study on 1,209 hospitalized children those with subgroup
A RSV infections required intensive care more often. These observations are not in
agreement with those that found no differences in the severity of disease relative to
subgroup A or B RSV infections (Mufson et al., 1991; Taylor et al., 1989; Salomon et
al., 1991; Russi et al., 1989; Monto and Ohmit, 1990; Hendry et al., 1989; Stark et al.,
1991; Tsutsumi et al., 1991; Kneyber et al., 1996). The present study found increased
bacterial binding to cells infected with either RSV subgroups, indicating that there is
probably no association with secondary bacterial infection and subgroups of the virus.
With the two isolates of M. catarrhalis tested in the assays, only the isolate able to grow
in the presence of selective antibiotics in modified New York City Medium (MCI)
showed enhanced binding to RSV-infected cells. The other isolate (MC2) was sensitive
to the antibiotics and bound in significantly lower levels to the viruses infected cells.
This was the first exception to the general pattern observed for bacterial binding to RSV
infected cells. The characteristics of the two isolates and additional isolates of M.
catarrhalis were examined further in the next chapter.
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Chapter 5
Characterisation of antibiotic-resistant and antibiotic-
sensitive strains ofM. catarrhalis
5.1 Introduction
M. catarrhalis is a normal inhabitant of the upper respiratory tract that is increasingly
recognized as a pathogen in certain clinical conditions (Berk, 1990; Catlin, 1990). M.
catarrhalis is the third most common cause of otitis media in children after S.
pneumoniae and non-typable H. influenzae (Van Hare et al., 1987). It also commonly
causes sinusitis and conjunctivitis in otherwise healthy children and elderly people
(Catlin, 1990). In addition to S. pneumoniae and H. influenzae, it is associated with
acute exacerbation of chronic bronchitis. In immunocompromised hosts, M.
catarrhalis can cause a variety of severe infections, including pneumonia, endocarditis,
septicaemia, and meningitis (Boyle et al., 1991; Catlin, 1990; Hager et al., 1987).
Prevalence studies suggest that as many as 50% of children are colonised with M.
catarrhalis (Ingvarsson et al., 1982; van Hare et al., 1987). The rate of colonisation is
highest in the early years and then steadily declines to < 5% in adulthood (Aniansson et
al., 1992; Ejlertsen, 1991). Increased colonisation with M. catarrhalis often occurs
during acute respiratory illness (Brodsky et al., 1991; Van Hare et al., 1987).
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With the recognition of M. catarrhalis as a human pathogen, studies of its surface
antigens are important to identify virulence factors and to understand pathogenesis
(Murphy, 1990). The presence of endotoxin in the M. catarrhalis outer membrane
undoubtedly contributes to its pathogenic potential, especially in situations in which
inflammation plays a major role (DeMaria, 1988).
It has been shown that complement is important in host defenses against infection with
Neisseriae (Densen, 1989); individuals with inherited complement deficiencies,
particularly those with a late complement component deficiency, have a markedly
increased risk (about 8,000-fold) of acquiring neisserial infections (Densen, 1989;
Densen, 1991). The role of complement in anti-neisserial defenses is emphasized by
the recognition of complement resistance among strains involved in systemic infections
(Densen, 1989). Studies on the resistance of M. catarrhalis strains to complement-
mediated killing found a wide variation in proportions of serum-resistant strains ranging
from 0 to 95% (Brorson et al., 1976; Chapman et al., 1985; Jordan et al., 1990; Soto-
Hernandez et al., 1989). A study by Verduin and colleagues (1994) found only 10% of
clinical isolates obtained from adults were complement sensitive. In contrast, most
isolates (58%) from healthy schoolchildren were sensitive to complement-mediated
killing. Some of the variation in the proportion of complement resistant isolates could
be due to differences in methods, source of complement, or definition of "resistance"
and "sensitive" by individual investigators (Hoi et al., 1993).
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The decreased binding of the antibiotic-sensitive strain of M. catarrhalis MC2 (Chapter
4) was the only exception to the pattern of enhanced binding to RSV-infected cells
observed for all the species tested; therefore, differences in other characteristics
associated with the two strains were examined.
5.1.1 Aims of the study
The objectives of this part of the project were:
1) to test a larger number of antibiotic-sensitive strains for their binding to RSV infected
cells to determine if this was a general pattern or an exceptional strain;
2) to determine if the differences in binding to RSV-infected cells were due to
differences in outer membrane proteins of the bacteria;
3) to compare the complement-mediated killing of the antibiotic-sensitive isolates of M.
catarrhalis with that resistant to antibiotics;
4) to assess the phagocytosis and intracellular survival of antibiotic resistant and
sensitive isolates.
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5.2 Materials and methods
5.2.1 Binding to RSV infected cells
The bacterial binding assays to HEp-2 cells and HEp-2 cells infected with RSV-A or
RSV-B were carried out as described in chapters 3 and 4.
5.2.2 Isolates and culture
In addition to the two isolates in chapter 4, 6 isolates of M. catarrhalis (MC3-MC8)
were obtained from the Clinical Bacteriology Laboratory, Department of Medical
Microbiology; each failed to grow on MNYC containing antibiotics. MCI was grown
on MNYC and antibiotic-sensitive isolates (MC2-MC8) were grown on boiled blood
agar (BBA). Isolates were grown overnight at 37°C in a humidified atmosphere with
10% CO2, harvested, washed three times in PBS by centrifugation at 2500 x g for 15
min and resuspended in MM without antibiotics by vigorous pipetting to disperse
clumps.
The bacterial concentrations were determined by measuring OD at 540 nm. For each
isolate the linear relationship between OD reading and total count assessed
microscopically with a Thoma counting chamber was determined, and a standard curve
was prepared for each isolate used.
5.2.3 Isolation ofM. catarrhalis outer membrane proteins (OMP)
The outer membrane proteins of each of the isolates was obtained from bacteria grown on
Columbia agar with horse blood grown overnight at 37°C in a humidified atmosphere
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with 10% CO2. The bacteria were harvested, washed 3 times in Tris buffer 0.01M (pH
7.4) and resuspended in 50 ml Tris buffer 0.01M. Bacterial cells were disrupted by
sonication (Probe-sonicator, MSE, Fisher scientific) for 15 min at 4000 microns.
Unbroken cells were removed by centrifugation twice at 3000 x g for 20 min. The
supernatant was then centrifuged at 100,000 x g (Ultra centrifuge, Beckman, USA) for
60 min at 4°C. The pellet was mixed with 20 ml of 1% (v/v) sodium N-lauryl
sarcosinate (Sarkosyl, Sigma) for 60 min at 37°C with shaking. This detergent
selectively solubilizes the inner membrane from the crude envelope preparations and
provides a method for obtaining the outer membrane (Hancock and Poxton, 1988). The
remaining outer membrane-peptidoglycan complex was sedimented by centrifugation at
60,000 x g for 60 min at 4°C, reconstituted in pyrogen free water and stored at -20°C.
The protein concentration was estimated by the method described by Bradford (1976).
5.2.4 Determination of OMP concentration
The outer membrane-peptidoglycan complex (0.1 ml) or bovine serum albumin as
standard were added to 5 ml of Bradford reagent as described in (2.7). The tubes were
mixed by inversion, and after 10 min the OD at 595 nm against reagent blank (reagent
only) were recorded. The OD of outer membrane sample was plotted with the standard
curve to calculate the protein concentration which was adjusted to 8 |lg protein before
separation by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE).
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5.2.5 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE) ofM. catarrhalis OMP
Outer membrane proteins were separated by SDS-PAGE using the SDS-discontinous
system of Laemmli (1970) on a mini-protein II cell (Bio-Rad Laboratories Ltd.,
Watford, Hertfordshire, UK). Equal volumes of protein sample and sample buffer [pH
6.8 (double-strength) containing Tris 0.125M, SDS 4% (w/v), 2-mercaptoethanol 2%
(v/v), glycerol 20% (v/v), and bromophenol blue 0.002% (w/v)] were mixed and heated
to 100°C for 5 min. Sample (20 pi) was applied to each lane and electrophoresis
carried out at a constant voltage of 100 V through the stacking gel (4% acrylamide) and
a constant voltage of 60 V through the separating gel (10% acrylamide). Proteins were
visualised by staining overnight with Coomassie blue (0.5% w/v) Coomassie brilliant
blue in (25% v/v) propan-2-ol + glacial acetic acid (10% v/v) followed by destaining
with 10% (v/v) glacial acetic acid 4 times for 1 hr intervals. Molecular weight markers
(Sigma) in the range of 29 to 205 kDa were run in parallel. The M. catarrhalis outer
membrane proteins were identified by their molecular weight previously reported by
Murphy (1990).
5.2.6 Complement-mediated killing assays
5.2.6.1 Sera
Sera from 14 post-mortem autopsies with no history of hospital admission before death
were obtained from the Lorensic Medicine Unit, Edinburgh University. There were 10
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sera from individuals 60 years of age or over (5 male and 5 female), and 4 sera from
individuals under 20 years of age (2 male and 2 female).
5.2.6.2 Complement
Serum from a donor of blood group AB was absorbed twice over a period of 24 h at 4°C
with a suspension of the 8 test isolates to remove any specific antibodies. The serum
was centrifuged (1500 x g) at 4°C and the remaining bacteria removed by filtration, first
with a filter with a pore diameter of 5 p.m (Nucleopore Corporation, Pleasanton, USA).
The absorbed serum was then passed through a sterilising filter with pore diameter of
0.22 (im (Nuflow cellulose acetate membrane, Oxoid). The minimum haemolytic titre
of the serum with sensitized sheep red blood cells (5.2.6.3) was determined by the
method described by Zorgani et al. (1996).
5.2.6.3 Preparation of sensitized sheep red blood cells
Whole blood taken aseptically from healthy sheep was supplied as a 50% (v/v) mixture
in Alsever's solution (SAPU). Fresh sheep red blood cells were washed twice in saline
by centrifugation at 450 x g for 5 min and the supernatant was removed. The red blood
cells were resuspended in saline (4%); this was checked by placing some of the
suspension in a haematocrit tube and centrifugation at 450 x g for 5 min. The donkey
anti-sheep antiserum (SAPU) was diluted 1 in 100 with saline and equal volumes of
donkey antiserum and sheep red blood cells were mixed and incubated at 37°C for 30
min. The sensitized sheep red blood cells were stored at 4°C until used.
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5.2.6.4 Bactericidal activity assay
Serum samples were heated at 56°C for 30 min to inactivate endogenous complement.
Each of the 96 wells of an 8 x 12 "U" well microtitre plate (Sterilin) was filled with 40
pi of Dulbecco's complete phosphate buffered saline containing supplement B
(DPBS+B) (pH 7.1). Each 100 ml DPBS was supplemented with 0.5 ml Dulbecco's B
containing calcium chloride (20 g l ') and magnesium chloride (20 g l1) (DPBS+B).
Heated inactivated neat serum (40 pi) was added to the first well in each column. A
series of seven two-fold dilutions was then made; 8 sera were tested per plate.
Overnight cultures of the two M. catarrhalis isolates (MCI and MC2) were harvested
from the medium and suspended in DPBS+B, and the number of bacteria estimated by
OD of the suspension at 540 nm (Zorgani et al., 1996). The bacteria were diluted to
provide a concentration of approximately lxl04 colony forming units (c f u ml '). To
each well in a plate was added 40 pi of one of the 2 bacterial suspensions. A 1/8
dilution of the absorbed complement source (20 pi) was added to all the test wells.
For each isolate and each serum specimen (dilution 1 in 5), there were 3 controls: one in
which the complement was replaced by PBS; one in which the serum was replaced by
PBS; one in which both serum and complement were replaced by PBS. The plates were
covered and incubated at 37°C for 30 min. Three 20 pi drops from each well were then
plated onto a BBA plate and incubated at 37°C overnight. The reciprocal of the highest
serum dilution at which there was at least an 80% decrease in viable count compared
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with the controls was recorded as the bactericidal titre. The bactericidal titres for MCI
and MC2 were determined under the same conditions at the same time.
5.2.7 Phagocytosis assay
5.2.7.1 Preparation of monocytes
Buffy coats from 7 donors were obtained from Scottish National Blood Transfusion
Service, Edinburgh. The samples were inverted to ensure thorough mixing, diluted 1 in
2 with 0.15 M saline and a 10 ml aliquot layered onto 3 ml cushions of Histopaque
(Sigma) in a 50 ml conical centrifuge tube. The cells were then centrifuged at 200 x g
for 25 min. Leukocytes were collected at the plasma / Histopaque interface by suction
through a Pasteur pipette and washed once at 100 x g for 10 min in PBS. The cells (50
|il) were diluted in white cell diluting fluid (450 |ll) containing gentian violet 1% (w/v)
in glacial acetic acid 1% (v/v). The cells were counted with a haemocytometer and
adjusted to give a concentration of lxl 06 ml 1 for the assay.
5.2.7.2 THP-1 cells
THP-1 cells (2.4.3) were grown routinely in RPMI 1640 with 10% FCS at 37°C in a
humidified 5% CO2 incubator in tissue culture flasks. THP-1 cells were harvested by
centrifugation at 300 x g for 10 min and resuspended in PBS. The cell count was
adjusted to give a concentration of lx 106 ml 1 for the assay.
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5.2.7.3 Binding assay
Two sets of tubes were prepared for each donor sample, the assay was carried out at two
different temperatures: 4°C (to examine binding) and 37°C (to examine binding and
ingestion). RSV infection of the cells (monocytes or THP-1) was assessed following
infection of the cells overnight at 37°C. Uninfected and RSV-A infected monocytes or
THP-1 cell suspensions (200 pi) and FITC conjugated bacteria (200 pi) (400 bacteria :
cell) were mixed and incubated for 30 min at each temperature. After incubation, the
unbound bacteria were removed and washed twice by centrifugation at 4°C with chilled
PBS (450 x g) and the cells fixed with buffered paraformaldehyde. The tubes were kept
in the dark at 4°C until analysis by flow cytometry.
5.2.7.4 Intracellular survival assays
Monocyte suspensions from 4 donors (200 pi, lxl06 cells ml ') and 200 pi of the
unlabelled M. catarrhalis isolates (MCI and MC2) at a ratio of 200 bacteria : cell were
mixed together in a 5 ml tube. The tubes were incubated for 30 min at 37°C in an
orbital incubator and washed three times at 300 x g for 10 min to remove non-bound
bacteria. Gentamicin (500 pi, lOmg ml" ) was added to the cells and incubated for 60
min at 37°C to kill bacteria attached to the cell surface. The cells were washed twice
with PBS, and 500 pi SDS (0.05% w/v) was added to lyse the cells and release the
intracellular bacteria. This preparation was further diluted 1/10 and 1/100 with PBS
and 3 (20 pi) drops of each dilution was plated onto BBA plates and incubated at 37°C
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for 48 hours. A colony count was then performed. The average of the 3 drops
determined and actual numbers of bacteria calculated by multiplying by 50 then by the
appropriate dilution factor.
5.2.8 Statistical methods (3.2.11)
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5.3 Results
5.3.1 Determination of infection of monocytes and THP-1 cells by
RSV
Infection of monocytes or THP-1 by RSV was assessed by direct immunofluorescence
assay as described in 3.2.6.1. The percentage of the positive cells detected per 100 cells
counted was 40-50 %.
5.3.2 Attachment ofM. catarrhalis isolates to RSV infected cells
Table 5.1 summarises the results of 6 experiments in which a ratio of 400 bacteria per
cell was used to assess the effect of infection with RSV-A or RSV-B on binding of
Moraxella isolates to HEp-2 cells. As the results observed with MC2 indicated,
decreased binding to RSV-infected cells was observed for the other 6 antibiotic-
sensitive isolates. The antibiotic-resistant M. catarrhalis isolate that grew on MNYC
showed significantly higher binding indices with RSV-A or RSV-B infected cells. The
binding indices of each of the antibiotic-sensitive isolates were significantly decreased
for the RSV-infected cells.
5.3.3 Comparison of OMPs among M. catarrhalis isolates.
The OMP of M. catarrhalis contains eight major proteins, the molecular weights of
these proteins range from 21 to 98 kDa, a typical OMP pattern for Gram-negative
bacteria. The OMP profiles of the antibiotic-resistant and the seven antibiotic-sensitive
isolates ofM. catarrhalis are shown in (Figure 5.1).
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MC8 MC7 MC6 MC5 MC4 MC3 MC2 MCI MW
Fig 5.1 Coomassie blue-stained 10% SDS-polyacrylamide gel containing OMP preparations of 8 different
strains of M. catarrhalis with low molecular-weight standard on the right.
*81 & 66 kDa proteins present in antibiotic-sensitive strains MC2-MC8
** 19 kDa protein present in antibiotic-resistant strain MCI
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Despite the diversity of the isolates, the results showed a high degree of similarity in
OMP patterns; however, the antibiotic-resistant isolate ofM. catarrhalis lacked bands at
81 kDa and 66 kDa which were present in the seven isolates which were antibiotic-
sensitive. The antibiotic-resistant isolate of M. catarrhalis had a distinct band at 19
kDa which was not present in the antibiotic-sensitive isolates.
5.3.4 Assessment of complement-mediated killing assay
The effects of complement killing of MCI and MC2 were assessed with serum samples
from 14 individuals. The antibiotic-sensitive isolate (MC2) was killed by dilutions of
serum ranging from 1/4-1/32. The antibiotic-resistant (MCI) was resistant at each of
the dilutions tested for the 14 sera (Table 5.2).
5.3.5 Assessment of phagocytosis and intracellular survival of
antibiotic-resistant and sensitive isolates
Assays were carried out to assess the differences in binding of the two isolates of M.
catarrhalis by uninfected or RSV-A infected monocytes or the THP-1 cell line.
Experiments were carried out at 4°C to assess binding separately from binding and
phagocytosis at 37°C. At 4°C there was a significant increase in binding of both MCI
and MC2 to monocytes from buffy coats or THP-1 cells infected with RSV-A. A
similar pattern was observed at 37°C (Tables 5.3 and 5.4).
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Table 5.2 Distribution of bactericidal titres against the two
M. catarrhalis isolates in the population tested
bactericidal





0 14 (100) 0
2 0 0
4 0 3 (21)
8 0 5 (36)
16 0 5 (36)






















































There were no differences found between the two isolates of M. catarrhalis on
intracellular survival within uninfected and RSV-A infected monocytes (Tables 5.5 a
and b).
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Tables 5.5 Comparison of intracellular survival of M. catarrhalis MCI and MC2








1 2.1xl04 1.6 xlO4 76
2 1.3 xlO4 2.2 xlO4 169
3 1.8 xlO4 1.9 xlO4 105
4 2.5 xlO4 2.5 xlO4 100
7








1 2.0 xlO4 1.6 xlO4 80
2 1.2 xlO4 2.0 xlO4 166
3 1.6 xlO4 2.1 xlO4 131
4 2.4 xlO4 2.5 xlO4 104
7
initial inoculm = 4x10
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5.4 Discussion
5.4.1 Results in relation to objectives of the chapter
The results obtained provided data to answer the questions posed in the introduction.
Since the decreased binding of the antibiotic-sensitive isolate of M. catarrhalis was the
only exception to the pattern of enhanced binding to RSV-infected cells observed with
all other species tested, 6 additional antibiotic-sensitive isolates were tested for their
binding to RSV-infected HEp-2 cells. The same pattern of significantly decreased
binding to RSV-infected cells compared to uninfected cells was observed.
OMP profiles of the antibiotic-resistant and the antibiotic-sensitive isolates of M.
catarrhalis showed a high degree of similarity in OMP patterns but there were
differences between the two groups. The antibiotic-resistant isolate lacked bands at 81
kDa and 66 kDa which were present in the seven antibiotic-sensitive isolates (MC2-
MC8). The antibiotic-resistant isolate (MCI) had a distinct band at 19 kDa which was
not present in the antibiotic-sensitive isolates (MC2-MC8).
All of the sera tested had bactericidal activity against the antibiotic-sensitive isolate
(MC2) with >80% reduction in viable bacteria compared with the control. None of the
14 sera showed complement mediated killing of the antibiotic-resistant isolate.
In contrast to results with the HEp-2 epithelial cell line, binding of both MCI and MC2
was significantly enhanced for RSV-infected monocytes or THP-1 cells. The
antibiotic-resistant isolate and antibiotic-sensitive isolate showed no differences in
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binding or phagocytosis compared to uninfected cells with either monocytes or the THP-
1 cell line. Although a high ratio of bacteria per cell was used in these experiments,
there was no differences observed between the two isolates of M. catarrhalis on
intracellular survival within uninfected and RSV-infected monocyte cells obtained from
buffy coats.
5.4.2 Results in relation to epidemiological and clinical reports
There is epidemiological evidence to suggest viral infection enhances colonisation by M.
catarrhalis. In a study in Denmark, significantly more children in the 1-48 month age
range with upper or lower respiratory tract infections were colonised with M. catarrhalis
(68%) compared with children without such infections (36%, P< 0.001). After
recovery, the isolation rate in the infected group fell to that of the uninfected group
(Ejlertsen et al., 1994). M. catarrhalis has been associated with various severe
infections in infants with chronic lung disease or in older compromised children (Cook
et al., 1989 and Korppi et al., 1990). Serological evidence suggests that M. catarrhalis
might be a potential bronchopulmonary pathogen even in children with no underlying
disease. Patients with serological evidence of M. catarrhalis infection often had a
concomitant viral infection caused by RSV (Korppi et al., 1992). In another study,
colonisation by M. catarrhalis was associated with other viral infections, mainly
parainfluenza infections (Nohynek et al., 1991).
138
5.4.3 OMP profile and serum sensitivity
The 81 kDa protein (CopB) is associated with serum sensitivity and clearance of this
organism from the lungs of mice. A mutant strain that did not express this protein
expressed wild type levels of serum resistance and the ability to resist pulmonary
clearance in vivo (Helminen et al., 1993a). A monoclonal antibody to the protein
bound to the majority (70%) of 23 M. catarrhalis strains which were obtained from
individuals at five different research centres across the United States (Helminen et al.,
1993b).
Helminen and colleagues (1993a) studied the effect of the CopB mutation on serum
resistance of M. catarrhalis to determine whether this mutation might also affect the
ability to survive in vivo in the lung of mice. The availability of this model facilitated
the in vivo evaluation of the isogenic CopB mutant, which was found to be much less
able to survive in the lungs of mice than was the wild-type parent strains. This
diminution of survival ability in vivo is likely directly related to the serum-sensitive
phenotype of the CopB mutant. The study did not assess the phagocytosis differences
between the serum resistance strain and its mutant. The results in this chapter showed
no differences in phagocytosis and killing between antibiotic-resistance and sensitive
strains by human monocytes.
Resistance to complement is an important virulence factor in certain Gram-negative
infections (Densen et al., 1987). The study by Smith and colleagues (1992) indicated
that resistance of gonococci to complement mediated killing by human serum was due
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to sialylation of their lipopolysaccharide which prevents bactericidal antibody from
reacting with target sites. Regardless of the role other components of the M.
catarrhalis outer membrane might play in serum resistance, the absence of CopB in the
outer membrane of the CopB mutant had a significant effect on serum resistance of M.
catarrhalis. Reintroduction of CopB into this mutant abolished the serum resistant
phenotype, confirming that CopB expression play a direct or indirect role in serum
resistance (Helminen et al., 1993a).
Published reports concerning the resistance of M. catarrhalis to killing by normal
human serum indicate that many strains of this pathogen are resistant to complement-
mediated lysis (Jordan et al., 1990; Soto-Hernandez et al., 1989; Chapman et al., 1985).
The study by Jordan and colleagues (1990) attempted to correlate serum resistance and
disease production by M. catarrhalis strains. It suggested that strains isolated from
infected sites are more likely to be serum-resistant than are strains isolated from the
sputum of healthy persons.
5.4.4 Future studies
The antibiotic sensitivity, adherence characteristics and complement resistance
properties of the M. catarrhalis antibiotic-resistant isolate (MCI) might contribute to its
pathogenicity in the respiratory tract. In the context of other studies, the present finding
suggests that the 81 kDa protein is associated with serum sensitivity and possibly
antibiotic-sensitive and reduced binding to RSV-infected epithelial cells. The
antibiotic-sensitive strains with these characteristics might be less likely to contribute to
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serious disease following RSV infection. The effect of prolonged antibiotic treatment
needed for patients with chronic lung disease on selection of resistant organisms needs
to be examined in complementary clinical and laboratory studies.
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Chapter 6
Binding of bacteria to HEp-2 cells infected with
influenza A virus
6.1 Introduction
Secondary bacterial infection is the most common, life threatening complication of
influenza infection (Kilbourne, 1987c). Influenza A virus infections in children are
often complicated by otitis media (Henderson et al., 1982; Wright et al., 1977; Wright et
al., 1980). It has been suggested that viral respiratory tract infections might predispose
to meningococcal disease (Moore et al., 1990). Epidemiological studies suggest that
influenza virus infection increases the risk of subsequent meningococcal infection
(Cartwright et al., 1991; Harrison et al., 1991).
While many studies have been carried out on binding of bacteria in animal models
(Plotkowski et al., 1986), there were no reports on the effect of influenza virus infection
on binding of bacteria to human respiratory epithelial cell lines. These studies were
initiated to determine if, like RSV, infection of epithelial cells with influenza A might
enhanced bacterial binding.
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6.1.1 Aims of the study
The objectives of this part of the study were:
1) to test the hypothesis that HEp-2 cells infected with human influenza A virus might
bind bacteria associated with meningitis or species associated with pneumonia, otitis
media and exacerbation of chronic bronchitis;
2) to determine if as reported for RSV-infected cells (Raza et al., 1994), there was an
increased expression of native cell surface antigens which can act as receptors for
bacteria;
3) to determine if neuraminidase affects bacterial binding to HEp-2 cells.
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6.2 Materials and methods
6.2.1 HEp-2 Cells (3.2.1)
6.2.2 Growth of influenza virus
6.2.2.1 MDCK cells (2 4 2)
6.2.2.2 Method
Confluent monolayers of MDCK cells were obtained in tissue culture flasks by
incubation in GM with 10% FCS. The monolayer was rinsed twice with DPBS+A to
remove the serum which contained substances that reduce virus infectivity. Influenza
virus type A, a recent isolate obtained from the Clinical Virology Laboratory, Edinburgh
University, was adsorbed to cells for 60 min at 37°C. The inoculum was removed and
replaced with serum free MM supplemented with 2 |ig ml 1 trypsin (crystalline, Sigma)
which is required for virus replication in this cell line. The cells were incubated at
37°C for 16-24 hr, the maximum time for the virus release. About two thirds of the
medium in the flask was discarded and the flask was frozen at -70°C and thawed to lyse
the cells. The suspension was centrifuged at 800 x g for 10 min. Aliquots of the
supernatant were stored at -70°C.
6.2.3 Titration of influenza A virus by haemagglutination assay
The samples of supernatant fluid were tested for presence of influenza virus by the
haemagglutination technique. Guinea pig erythrocytes obtained from the Transgenic
Unit, Department of Medical Microbiology, Edinburgh University were washed and
suspended (0.5% v/v) in Complement Fixation Test (CFT) buffer, prepared from tablets
144
(Oxoid) (pH 7.2). Diluted guinea pig erythrocytes (25 pi) were added to 25 pi of two
fold serial dilutions of influenza supernatant fluids in a microtitre plate containing 96
"V" shaped wells with the same buffer and incubated for 1 h at room temperature. The
virus preparation with the highest haemagglutination titer was frozen in 2 ml aliquots at
-70°C until used.
6.2.4 Detection of influenza infected cells
6.2.4.1 Direct immunofluorescence
Coverslips with confluent monolayers of HEp-2 cells in a 24-well plate were prepared
and infected with influenza virus aliquots (200 pi) at different dilutions (1/2, 1/5 and
1/10) for 1 hr at 37°C, and the inoculum was replaced with 1 ml serum free MM. The
cells were incubated at 37°C for 16-24 hr.
Monolayers were fixed with acetone (BDH) for 5 min. The percentage of infected cells
was determined for each dilution by incubating the coverslips with 25 pi of the FITC-
labelled reagent for detection of influenza A virus (2.6.2). The slides were dried and
mounted with 50% glycerol in PBS. They were examined with an ultraviolet
microscope (Microstar IV, Reichert, Buffalo, New York, USA) for the proportion of




Sources of the following strains of N. meningitidis, S. pneumoniae, H. influenzae, B.
pertussis, N. lactamica, M. catarrhalis and S. aureus, their culture conditions and
enumeration were described in (3.2.3, 4.2.3 and 5.2.2).
6.2.6 Infection of HEp-2 cells with influenza A virus
3
Overnight monolayer cultures of HEp-2 cells in culture flasks (75 cm ) were infected
with influenza A, 5 ml of a 1 : 5 dilution of the virus suspension in serum free MM was
adsorbed for 1 hr. The fluid was replaced with 25 ml serum free MM and incubated
overnight at 37°C. The monolayers were rinsed twice with sterile DPBS+A and
harvested by adding 5 ml of EDTA (0.05% v/v) per flask at 37°C for 5-10 min. MM
(5ml) was added to the cells to counteract EDTA activity. The cells were centrifuged at
460 x g for 7 min and resuspended in MM without antibiotics, counted and adjusted to
lxlO6 cells ml 1.
6.2.7 Bacterial Binding to influenza A-infected HEp-2 cells
Bacterial binding studies were carried out and analysed by flow cytometry as described
previously.
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6.2.8 Detection of host cell surface antigens on HEp-2 cells infected
with influenza virus
Binding of monoclonal antibodies to host cell surface antigens to HEp-2 cells and HEp-
2 cells infected with influenza virus (200 |il, lxlO6 ml"') was assessed by the method
described in 3.2.9.
6.2.9 Inhibition of bacterial binding by pre-treatment of Flu-A
infected HEp-2 cells with antibodies to host cell antigens
Influenza A-infected HEp-2 cells were treated with monoclonal antibody to CD14 or
CD 18 as described in 3.2.10. The attachment assays with FITC-labelled Gram-negative
species (N. meningitidis, M. catarrhalis, H. influenzae type b) or Gram-positive species
(S. pneumoniae and S. aureus), were performed and analysed as described in 3.2.7.
6.2.10 The effect of pre-treatment of HEp-2 cells with neuraminidase
on bacterial binding
HEp-2 cell (200 |il, lx 106 cells ml"1) were incubated with neuraminidase type III from
Vibrio cholerae (Sigma) (30 (0.1, 1 unit ml }) for 60 min at 37°C. The cells were washed
twice with PBS. The FITC-labelled N. meningitidis strain (C: 2b: PI.2) (200 bacteria :
cell) or S. aureus strain (NCTC 10655) (200 bacteria : cell) were incubated with equal
volumes of HEp-2 cells and HEp-2 cells pre-treated with neuraminidase at 37°C for 30
min. The cells were washed three times at 460 x g with PBS and analysed by flow
cytometry (3.2.7).
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6.2.11 The effect of pre-treatment of HEp-2 cell with neuraminidase
on detection of host cell surface antigens
HEp-2 cell (200 pi, lx 106 cells ml"1) were incubated with neuraminidase as described
in 6.2.10 for 60 min at 37°C. The cells were washed twice with PBS and incubated for
60 min at 37°C with the same dilutions of antibodies as in 3.2.9 and antibody to H type
2 (1/10). The cells were washed twice with PBS and incubated for 30 min in an orbital
shaker at 37°C with FITC-labelled secondary antibodies used to detect binding of their
respective primary antibody. FITC labelled secondary antibodies were incubated with
HEp-2 cells or neuraminidase treated HEp-2 cells incubated with PBS but no primary
antibody as a control for non-specific binding. The cells were washed three times at
460 x g with PBS and analysed by flow cytometry (3.2.7).
6.2.12 Statistical methods.
The data were assessed by estimate of relative binding of the bacteria to influenza A-
infected HEp-2 cells compared with uninfected cells based on paired f-tests applied to
logarithms of the binding indices.
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6.3 Results
6.3.1 Determination of influenza A-infected HEp-2 cells
The proportion of influenza A-infected HEp-2 cells at 24 h post inoculation assessed by
direct immunofluorescence at the time of the attachment assay was >75 %.
6.3.2 Attachment of Gram-negative species to influenza A-infected
HEp-2 cells
The ratios of bacteria per cell used in these studies were the same as those used in
experiments with RSV-infected cells in chapters 3 and 4 as the uninfected HEp-2 cells
were the standard for comparison with virus infected cells. Tables 6.1 and 6.2
summarise the results of 6 experiments to assess the effect of infection with influenza A
virus on binding to HEp-2 cells by Neisseria, Haemophilus, Moraxella, and Bordetella
species. Each isolate was tested at a ratio of 200 bacteria per cell except for M.
catarrhalis 400 bacteria : cell and B. pertussis which was used at 500 bacteria per cell.
All the bacterial species showed enhanced binding to cells infected with influenza A
compared with uninfected HEp-2 cells, including the antibiotic-sensitive isolate of M.
catarrhalis.
6.3.3 Attachment of Gram-positive species to uninfected and
influenza A-infected HEp-2 cells
Binding of S. aureus, S. pneumoniae strains associated with meningitis and
pneumococcal strains associated with respiratory infections to uninfected and influenza-
infected cells was assessed in 6 experiments in which ratios of 200 bacteria per cell
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Table 6.2 Results of 6 experiments on binding ofM. catarrhalis isolates
to uninfected HEp-2 cells and HEp-2 cells infected with










MCI 37419 52442 288 (261- 318) 0.001
MC2 39743 60986 421 (354- 500) 0.001
MC3 47743 56143 197(165- 234) 0.001
MC4 49491 68211 321 (258- 399) 0.001
MC5 54145 66768 335 (299- 375) 0.001
MC6 41145 62384 323 (260- 402) 0.001
MC7 54416 67595 314(252- 392) 0.001
MC8 38276 63355 442(256- 764) 0.001
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were used. Influenza virus infected HEp-2 cells had significantly higher binding
indices compared with binding indices for uninfected cells (Table 6.3).
6.3.4 Binding ofN. meningitidis LOS immunotype strains to influenza
A-infected HEp-2 cells
Strains with different LOS immunotype antigens, were assessed for binding to
determine if the carbohydrate composition of the endotoxin affected binding to virus
infected cells. In 5 experiments each of 12 immunotype strains exhibited significantly
enhanced binding to cells infected with influenza A virus compared to uninfected cells
(Table 6.4).
6.3.5 Expression of cell surface antigens on HEp-2 cells infected with
influenza virus
In 3 experiments the binding indices for monoclonal antibodies directed towards cell
surface antigens indicate there was no significant difference in binding of monoclonal
b x
antibodies to Le , Le or H type 2 to HEp-2 cells or HEp-2 cells infected with influenza
virus. There were significant increases in binding of anti-CD 14 (P< 0.05, 95% CI 182-
2188) and anti-CD 18 (P< 0.001, 95% CI 514-684) monoclonal antibodies to HEp-2
cells infected with influenza virus compared to uninfected HEp-2 cells (Table 6.5).
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Table 6.5 Binding indices for monoclonal antibodies to host cell surface
antigens on HEp-2 cells and influenza-A infected HEp-2 cells
Antibodies mean BI of
uninfected cells
mean BI of flu-A
infected cells
95% CI P
Lewisb 1782 1496 64-111 NS
LewisX (CD15) 1241 1143 69-123 NS
H type 2 790 680 67-126 NS
CD 14 1933 10984 182-2188 0.05
CD 18 2173 12901 514-684 0.001
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6.3.6 Inhibition of bacterial binding
In 4 experiments binding of N. meningitidis (C: 2b: PI.2), M. catarrhalis strains MCI
and MC2 and the type b H. influenzae isolate to influenza A-infected HEp-2 cells was
inhibited by anti-CD 14 or anti-CD 18. The results showed significant reduction in
binding by anti-CD14 for each species tested: N. meningitidis (P< 0.001, 95% CI 55-
62); M. catarrhalis (MCI) (P< 0.001, 95% CI 47-61); MC2 (P< 0.01, 95% CI 52-69);
and H. influenzae type b (P< 0.001, 95% CI 43-52). A similar pattern was observed for
anti-CD18: N. meningitidis (P< 0.001, 95% CI 45-53); M. catarrhalis (MCI) (P< 0.01,
95% CI 37-62); MC2 (P< 0.001, 95% CI 50-64); and H. influenzae type b (P< 0.001,
95% CI 39-45) (Fig 6.1).
With Gram-positive species, no significant reduction in binding was observed.
Binding indices for S. aureus to influenza A infected cells treated with anti-CD14 (95%
CI 87-106) or anti-CD 18 (95% 90-106) showed no differences compared with untreated
cells. A similar pattern was observed with S. pneumoniae (12F) with anti-CD 14 (95%
CI 95-107) or anti-CD 18 (95% CI 96-108) (Fig 6.2).
6.3.7 The effects of neuraminidase treatment on bacterial binding
In 3 experiments the binding indices of S. aureus strain (NCTC 10655) and N.
meningitidis strain (C:2b:P1.2) to HEp-2 cells pre-treated with neuraminidase were
compared with their binding indices to untreated HEp-2 cells (Fig 6.3 and 6.4). The
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Figure 6.1 The effect of pre-treatment of influenza A infected HEp-2 cells with
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Figure 6.2 The effect of pre-treatment of influenza A infected HEp-2 cells with
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Figure 6.3 The effect of pre-treatment of HEp-2 cell with neuraminidase on binding of
S. aureus strain (NCTC 10655) compared with their binding to uninfected HEp-2 cells










Figure 6.4 The effect of pre-treatment of HEp-2 cell with neuraminidase on binding of
N. meningitidis (C:2b:P1.2) compared with binding to uninfected HEp-2 cells and
influenza A-infected cells.
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(NS, 95 % CI 99-125), but marginally significant (P< 0.05, 95 % CI 105-139) for S.
aureus.
6.3.8 The effects of neuraminidase treatment on detection of host cell
surface antigens
In 3 experiments the binding indices for monoclonal antibodies directed to cell surface
antigens indicate there was no significant difference in binding of monoclonal
b x
antibodies to Le , Le or H type 2 to HEp-2 cells or HEp-2 cells treated with
neuraminidase. There were significant increases in binding of anti-CD 14 (P< 0.01,
95% CI 220-350) and anti-CD18 (P< 0.01, 95% CI 256-359) monoclonal antibodies to













1000 H n m □ PBS■ Neuraminidase
Leb Lex H2 CD14 CD18
Cell surface antigens
Figure 6.5 Binding of monoclonal antibodies to host cell surface antigens on HEp-2
cells treated with PBS or neuraminidase.
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6.4 Discussion
6.4.1 Results in relation to objectives of the chapter
The results of this study answered the questions posed in the introduction. HEp-2 cells
infected with human influenza A virus showed increased adherence of respiratory tract
bacteria associated with meningitis, pneumonia and exacerbation of chronic bronchitis.
In contrast to studies with RSV, the antibiotic-sensitive isolates (MC2-MC8) of M.
catarrhalis also showed significantly increased binding to cells infected with influenza
virus. Influenza virus infected HEp-2 cells showed no changes in expression of Lewis
antigens or H type 2, but significantly increased binding of monoclonal antibodies for
the cell surface antigens CD14 and CD18 compared to uninfected HEp-2 cells. In
contrast, RSV infection enhanced binding of Lewis as well as to CD 14 and CD 18
(Raza et al., 1994).
Pre-treatment of the virus infected cells with anti-CD 14 or anti-CD 18 significantly
reduced binding of Gram-negative species tested but not the Gram-positive species.
Treatment of uninfected HEp-2 cells with neuraminidase enhanced bacterial binding
which might be an additional mechanism by which influenza infection increases the
accessibility of host cell antigens to which bacteria bind. Neuraminidase treatment
significantly enhanced binding of S. aureus. This was suggested to be due to removal
X X
of sialic acid from sialyl Lewis as Lewis has been shown to be a receptor for S. aureus
X
(Saadi et al., 1996); however there was no changes in binding of anti-Lewis to
neuraminidase treated cells. The enhanced binding observed with N. meningitidis and
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neuraminidase treated cells was not significant. This could be due to small number of
experiments. Binding of anti-CD 14 and anti-CD 18 to the neuraminidase treated cells
was significantly enhanced.
Monoclonal antibodies to influenza antigens such as the haemagglutinin were not
available, so these were not tested.
6.4.2 Secondary respiratory infection and influenza
Several possible mechanisms for promoting bacterial superinfection by influenza have
been proposed. These include: decreased tracheal clearance function (Sweet and Smith,
1980; Nugent and Pesanti, 1983); impairment in pulmonary and systemic bacterial
clearance mechanisms (Warshauer et al., 1977). Studies by Sanford and colleagues
(1978; 1979), and Davison and Sanford (1981) suggest the possibility that influenza
infection predisposes the host to bacterial colonisation, and subsequent disease by
enhancing the adherence of some bacteria to virus-infected respiratory tract cells. This
hypothesis is, in fact, consistent with clinical, epidemiological, and experimental
evidence which indicates that influenza A infection predisposes the lungs to secondary
pneumonia due to S. aureus, S. pneumoniae, and to a lesser extent, H. influenzae
(Nugent and Pesanti, 1983). Vaccination against influenza virus type A before an
influenza A epidemic has been shown to be effective in preventing the development of
AOM in children aged between 1-3 years (Heikkinen et al., 1991). In the present study
each of the bacterial strains associated with AOM or pneumonia showed enhanced
binding to influenza infected cells.
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6.4.3 Bacterial meningitis and influenza
Many children with bacterial meningitis had signs and symptoms of upper respiratory
infection, suggesting that viral infection could lead to secondary bacterial invasion
(Fulginiti and Sieber, 1975). While recent epidemiological studies found little evidence
to suggest RSV is associated with outbreaks of meningococcal infection (Stuart et al.,
1996), there is evidence that influenza virus infection might increase the risk of
subsequent meningococcal infection (Cartwright et al., 1991; Harrison et al., 1991). In
the experiments carried out in this project, both viruses enhanced binding of all
meningococcal isolates tested, regardless of serogroup, serotype, subtype or
immunotype.
Influenza virus is also known to affect cellular immunity adversely (Notkins et al.,
1970; Kantzler et al., 1974; Jakab, 1982). It has been suggested that influenza-induced
coughing causes aerosolization and, therefore, increased transmission of N.
meningitidis. All of these findings could, alone or in combination, account for the
association between these two infections.
6.4.4 Host cell receptors for bacteria and influenza infection
6.4.4.1 CD14 and CD18
CD 14 and CD 18 are receptors for Gram-negative bacteria such as Escherichia coli
(Wright and Jong, 1986; Wright et al., 1989). Influenza virus infected HEp-2 cells
showed significantly increased binding of monoclonal antibodies for the cell surface
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antigens CD 14 and CD 18 compared to uninfected HEp-2 cells. This might partly
explain how virus infection contributes to enhanced binding by upregulation of
expression of host cell surface antigens that can act as receptors for the Gram-negative
bacteria.
Pre-treatment of influenza A virus infected HEp-2 cells with monoclonal antibodies to
CD 14 or CD 18 significantly inhibited binding of Gram-negative species tested (N.
meningitidis, M. catarrhalis, and H. influenzae type b). While it could be argued that
this effect was due to stearic hinderance, there was no effect on inhibition of binding of
Gram-positive species tested. This indicates that the endotoxin of Gram-negative
bacteria are involved in enhanced binding of Gram-negative species observed for virus
infected cells.
6.4.4.2 Effect of neuraminidase
HEp-2 cells pre-treated with neuraminidase showed significantly increased binding of S.
aureus compared to untreated HEp-2 cells while the binding of meningococci was
increased, the results were not significant. Differences in binding to enzyme treated
cells and influenza infected cells indicates neuraminidase contributes to but is not the
only effect on cells that could enhance binding.
Sialic acid is present on the structure of both CD 14 molecules (Stelter et al., 1996) and
CD 18 molecules (Kerr and Stocks, 1992) and neuraminidase treatment appears to make
the epitope to which monoclonal reagents bind more accessible. Studies by Spooncer
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and colleagues (1984) and Fukuda and colleagues (1984) had shown by carbohydrate
analysis that two of the major carbohydrate structures carried by neutrophil
glucoproteins are large highly branched N-linked structures: a polyfucosylated
lactosaminoglycan and a sialylated fucosyl-lactosaminoglycan; both of these carry the
X
CD 15 determinant. The sialylated derivative sLe is not recognized by the CD 15
antibodies unless the sialic acid is remove. Removing of sialic acid from the host cell
antigens molecules by neuraminidase treatment might expose epitopes masked by sialic
acid residues; however, enhanced binding of monoclonal anti CD 15 was not observed.
An addition to the various mechanisms proposed to explain why influenza A is a
predisposing factor for bacterial disease of the respiratory tract and meningitis, these
studies indicate that virus infected epithelial cells bind more bacteria. If a similar
phenomenon occurs in vivo, this could contribute to density of colonisation which is an
important factor in development of bacterial disease.
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Chapter 7
The effect of smoking on adherence of respiratory
pathogens to epithelial cells
7.1 Introduction
Smoking is associated with an increased risk of respiratory tract infection in adults
(Aronson et al., 1982) and also with carriage of some potentially pathogenic species of
bacteria (Musher and Fainstein, 1981; Blackwell et al., 1990; Blackwell et al., 1992).
Young smokers had an approximately two fold greater risk of developing infection
compared to non-smokers. Smokers were more likely to develop a lower respiratory
tract infection, and they were also symptomatic for a 25% longer period (Aronson et al.,
1982).
Although there is no association between meningococcal disease and active smoking,
isolation of N. meningitidis from the nasopharynx is significantly greater among
smokers, and heavier smokers are more likely to be carriers of meningococci (Stuart et
al., 1989; Blackwell et al., 1990; Blackwell et al., 1992). Passive exposure to cigarette
smoke is a risk factor for meningococcal infection in children (Stuart et al., 1988;
Haneberg et al., 1983). Passive exposure to cigarette smoke is associated with
respiratory tract infections in children, and in many studies the strongest association was
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with maternal smoking (Pershagen, 1986). Greek schoolchildren from households in
which the mother or other members of the family traditionally involved in child care
smoked were more likely to be carriers of meningococci than children from households
in which no one smoked (Kremastinou et al., 1994).
Cigarette smoking remains the most common cause of chronic bronchitis, although
recurrent childhood respiratory infections and air pollution play important roles in the
pathogenesis of this disease (Cazzola, 1990). Bacteria commonly isolated from the
sputum of patients with chronic bronchitis include non-typable H. influenzae, S.
pneumoniae, S. aureus and M. catarrhalis. These bacteria are found at both
exacerbation and times of remission (Lampe et al., 1982).
Several studies showed that smokers have increased bacterial adherence to pharyngeal
and epithelial cells (Musher and Fainstein, 1981; Mahajan and Panhotra, 1989). H.
influenzae (CCUG21594) and S. pneumoniae (CCUG10175) have been shown by
interference contrast microscopy to attach more readily to pharyngeal cells from
smokers with chronic bronchitis (Riise et al., 1994). While a number of host cell
antigens have been identified to act as receptors for bacteria (Table 7.1), the effect of
smoking on expression of these antigens has not been assessed.
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Table 7.1 Bacterial species and host cell antigens which act as receptors
Species Antigen References
B. pertussis X SLLewis , Lewis van t'Wout et al, 1992
Saadi et al, 1996
S. aureus X <1Lewis , Lewis
Fibronectin
Saadi et al, 1993
Ljungh andWadstrom 1996
H. pylori Lewis'3
H type 2, Lewis3
Boren et al, 1993
Alkout et al, 1997
E. coli CD 14, CD18 Wright and Jong, 1986
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7.1.1 Aims of the study
This study used the flow cytometry method to determine:
1) if there was enhanced binding to cells of smokers by bacteria in which the
epidemiological studies found disease or carriage of the bacteria was associated with
smoking or passive exposure to cigarette smoke;
2) if cells of smokers expressed higher levels of antigens proposed to act as bacterial
receptors;
3) if cells of non-smokers treated with a water soluble extract of cigarette smoke could
enhance bacterial binding.
171
7.2 Materials and Methods
7.2.1 Collection of epithelial cells
Buccal epithelial cells (BEC) were obtained from donors in the Department of Medical
Microbiology by rubbing the inside of the oral cavity with cotton swabs. To remove the
cells, the swabs were agitated in 10 ml PBS. They were washed twice in PBS in a
Sorvall RT 6000 centrifuge at 300 x g for 10 min and the concentration adjusted to 2.5 x
105 ml ' after determination of the number of cells microscopically in an improved
Neubauer haemocytometer (Weber Scientific International Ltd, UK).
7.2.2 Bacteria
Sources of strains of N. meningitidis, S. pneumoniae, H. influenzae, B. pertussis, N.
lactamica, M. catarrhalis and S. aureus and their culture conditions were described in
chapters 3, 4 and 5. The bacteria were harvested, washed three times in PBS by
centrifugation at 2500 x g for 15 min and resuspended in MM without antibiotics by
vigorous pipetting to disperse clumps. The bacterial concentrations were determined by
measuring OD at 540 nm (3.3.1 and 4.3.1).
7.2.3 Bacterial binding to buccal epithelial cells of smokers
& non-smokers
Bacteria were labelled with FITC as described in chapter 3 and the binding studies with
cells from smokers and non-smokers carried out as described for HEp-2 cells. Dose
response experiments were carried out with cells of non-smokers to determine the
optimal ratios of each bacterial strain.
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7.2.4 Preparation of water soluble components of cigarette smoke
A hand operated vacuum pump was used to draw cigarette smoke through sterile PBS.
The apparatus consisted of a 250 ml Duran bottle with two holes drilled in the cap.
Through one of these holes was placed a length of sterilised tubing with a connection to
a piece of larger bore tubing which held the cigarette. Another length of tubing was run
from the other hole to the vacuum pump. The cigarette smoke was drawn through the
medium by the change in pressure caused by extracting the air from the upper part of the
bottle (Figure 7.1). The smoke from 10 cigarettes (Regal King Size) was infused into
100 ml of the PBS to provide a stock solution of 0.1 cigarettes / ml. The medium was
filter sterilised using a 0.2 |im Millipore syringe filter and frozen in aliquots at -20°C
prior to use.
7.2.5 Treatment of BEC from non-smokers with water soluble
components of cigarette smoke
BEC from non-smokers (200 pi, 2.5 x 105 ml"') were incubated with various dilutions
the cigarette smoke extract (CSE) (500 pi) for 30 min at 37°C. The cells were washed
twice with PBS by centrifugation at 300 x g for 10 min, then the cells were used for
bacterial binding as described in chapter 3.
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Figure 7.1 Apparatus used in the production of the water soluble components
of cigarette smoke.
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7.2.6 Detection of host cell surface antigens on EEC of smokers and
non-smokers
BEC from smokers and non-smokers were assessed for expression of CD14, CD18, H
type 2, and Lewis antigens as described in 3.2.9 and 6.2.11. For detection of fibrinogen
and fibronectin, BEC from smokers and non-smokers were incubated with sheep
polyclonal anti-human fibrinogen (Sigma) diluted 1 in 10 or sheep polyclonal anti-
fibronectin (Sigma) diluted 1 in 10 for 60 min at 37°C. The cells were washed twice
with PBS and incubated with donkey anti-sheep / goat IgG conjugated with FITC
diluted 1 in 100 for 30 min in an orbital shaker at 37°C. The cells were washed twice
with PBS by centrifugation, resuspended in 1% buffered paraformaldehyde and analysed
with an EPICS-XL flow cytometer. Controls included cells incubated without either
primary or secondary antibodies and cells incubated only with the secondary antibody.
7.2.7 Detection of host cell antigens on BEC of non-smokers treated
with CSE
BEC (200 ]il, 2.5 x 105 ml ') from non-smokers treated with PBS or CSE (7.2.5) were
added to Falcon tubes containing 200 pi of monoclonal antibodies to Le'1 (1/5), Le*
(1/10), Leb (1/10), or H type 2 (1/10). The tubes were incubated at 37°C for 60 min,
washed twice with PBS by centrifugation at 300 x g for 10 min and incubated with 200
pi rabbit anti-mouse IgM conjugated with FITC diluted 1 in 200. The FITC-labelled
antibody was also added to 200 pi of cells which had not been treated with the first
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antibody as a control. The tubes were incubated at 37°C for 60 min with continuous
shaking. The cells were washed twice with PBS and fixed with 200 pi of 1% buffered
paraformaldehyde and stored in the dark at 4°C until analysed. The cells were analysed
with an EPICS-XL flow cytometer (3.2.7).
7.2.8 Enzyme linked immunosorbent assay (ELISA) to detect H
antigen
Microtitre plates (96 wells) were coated with 100 (il of CSE (undiluted, 1/10, 1/20, 1/40
and 1/80) diluted in coating buffer and incubated overnight at 4°C. The plates were
washed with washing buffer (2.8.2), blocked with blocking buffer (2.8.3) and incubated
at room temperature for 20 min. The blocking buffer was removed and the plates
washed with washing buffer.
Biotinylated Ulex europaeus lectin (which detects H antigen) was diluted to 5 pg ml 1 in
blocking buffer (2.8.3) and 100 jllI was added to the wells and incubated at 37°C for 30
min. The plates were then washed 6 times with washing buffer (2.8.2). Streptavidin-
HRP (Sigma) (100 |ll) diluted 1 in 100 in blocking buffer was added to the plates and
incubated for 60 min at room temperature then washed 6 times in washing buffer. The
substrate (2.8.5) (100 pi) activated by 40 ml H2O2 (30 % v/v) immediately before use
was added. The colour change was stopped after 10 min by adding 100 pi of
H2SC>4.(12.5%). The optical density at 490 nm was determined by an ELISA reader
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(Dynatech) and corrected by subtracting the OD of the corresponding blank well
containing smoke extract, streptavidin-HRP and substrate. Saliva from an individual of
blood group O who secreted H type 1 and Lewis blood group antigens was used as
positive control.
7.2.9 Statistical analysis
The assessment of the data on bacterial binding to cells of smokers and non-smokers
was based on paired r-test applied to logarithms of the binding indices.
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7.3 Results
7.3.1 Determination of the ratio of bacteria per cell
Dose response experiments were carried out with buccal epithelial cells for each strain:
N. meningitidis (Figure 7.2); S. pneumoniae (Figure 7.3); H. influenzae (Figure 7.4); M.
catarrhalis (Figure 7.5); N. lactamica (Figure 7.6). For experiments in which binding
of bacteria to cells from smokers and non-smokers was assessed, a ratio of bacteria : cell
at the midpoint of the dose response curve for the non-smoker was used. Data from
previous studies on bacterial binding to BEC of smokers and non-smokers in the
laboratory indicated optimal levels of S. aureus and B. pertussis were 500 : cell and 640
: cell respectively (Saadi et al., 1994; Saadi et al., 1996).
7.3.2 Binding of Gram-negative species to buccal epithelial cells
of smokers and non-smokers
Compared with binding indices for cells from non-smokers, those obtained for N.
meningitidis strains with epithelial cells from smokers were significantly increased. A
similar pattern was found with the two non-typable isolates of H. influenzae (87D),
(24ID) and the serotype b isolate. For the two Moraxella isolates (MCI) and (MC2),
binding to cells of smokers was significantly increased compared to binding to cells of
non-smokers. Both N. lactamica and B. pertussis showed significantly higher binding


















Figure 7.2 Representative dose response curves obtained with 4 N. meningitidis strains




















Figure 7.3 Representative dose response curves obtained with 3 S. pneumoniae strains



















Figure 7.4 Representative dose response curves obtained with 3 H. influenzae (type b
and non-typable) isolates for binding to BEC of non-smokers.
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Bacteria: cell
Figure 7.5 Representative dose response curves obtained with 2 M. catarrhalis isolates















Figure 7.6 Representative dose response curve obtained with N. lactamica isolate (LOl)
for binding to BEC of non-smokers.
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7.3.3 Binding of Gram-positive species to buccal epithelial cells
of smokers and non-smokers
S. aureus, S. pneumoniae serotypes associated with meningitis and those associated
respiratory infections were examined for binding to cells of smokers and non-smokers.
The binding indices of the each isolate was significantly greater for cells from smokers
compared with non-smokers (Table 7.3).
7.3.4 Effects of undiluted water soluble components of cigarette
smoke on bacterial attachment
BEC from non-smokers were treated with undiluted water soluble components of
cigarette smoke as described in (7.2.5). The bacterial species tested in these assays
were three strains of N. meningitidis (C: 2b: PI.2, NG: 2b: PI. 10 and B: 2b: PI. 10), one
strain of N. lactamica (LOl), one strain of H. influenzae (type b) and the two isolates of
M. catarrhalis (MCI and MC2). There was significantly decreased binding of each
isolate to BEC treated with undiluted extract of smoke components compared to
untreated BEC of the same non-smokers (Table 7.4).
7.3.5 Effects of dilution of water soluble components of cigarette
smoke on bacterial binding
To determine the effect of concentration of the cigarette smoke extract on bacterial
binding, in three experiments BEC from a non-smoker were treated with different
dilutions of the water soluble components of cigarette smoke (1/10 to 1/1280). From
the 1/10 dilution to the 1/320 dilution, there was enhanced binding of S. pneumoniae
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(12F) (Figure 7.7). At the 1 in 640 dilution the effect of the extract was no longer
observed.
7.3.6 Effects of diluted water soluble components of cigarette smoke
on bacterial binding to BEC from additional non-smokers
To determine if the effect of the cigarette smoke extract was limited only to the cells of
the non-smokers in 7.3.5, BEC from 7 other non-smokers were treated with the cigarette
smoke extract diluted 1 in 10 (7.2.5). Binding of different bacterial species including
N. meningitidis, M. catarrhalis, H. influenzae type b, N. lactamica, S. pneumoniae and
B. pertussis to cells treated with the extract diluted 1 in 10 was compared with that for
untreated cells (7.2.5). The results indicate there was significantly increased bacterial
attachment to BEC treated with the diluted extract (Table 7.5).
7.3.7 Detection of surface antigens on BEC of smokers and non-
smokers
In experiments with 8 pairs of smoker and non-smoker donors, there were no significant
differences in binding of monoclonal or polyclonal antibodies to Lea, Le^, LeX, H type
2, fibrinogen or fibronectin to BEC from smokers and non-smokers. The amount of
CD 14 or CD 18 detected was too small to analyse (Table 7.6).
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Figure 7.7 The effect of different dilutions of cigarette extract on binding of
S. pneumoniae type 12F compared with untreated BEC.
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Table 7.6 Expression of surface antigens on buccal epithelial cells
of smokers and non smokers





Lewis3 8 761 840 NS
Lewisb 8 1314 1118 NS
LewisX 8 625 458 NS
H type 2 8 2263 2089 NS
Fibronectin 8 1249 1105 NS
Fibrinogen 8 1265 1655 NS
Binding of monoclonal antibodies for CD 14 and CD 18 was too low to analyse
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7.3.8 Effects of water soluble components of cigarette smoke on
detection of cell surface antigens
Cells of 7 non-smoker donors were treated with PBS or CSE diluted 1 in 10. The
binding indices of monoclonal antibodies to the following antigens were significantly
decreased for the cells treated with CSE compared with untreated BEC of the same
donors, Lea (63%, P< 0.01, 95% CI 49-82); Leb (80%, P< 0.05, 95% CI 66-97); LeX
(47%, P< 0.01, 95% CI 34-67). The only exception was the binding index of the
monoclonal antibody to H type 2; this was significantly increased (120%, P < 0.01, 95%
CI 133-180) for the CSE treated cells compared with untreated BEC of the same donors
(Fig 7.8).
7.3.9 ELISA to detect H type 2 in CSE
The result of the spectrophotometer assays showed that a fucose containing substance
which bound the biotinylated Ulex europaeus lectin was present in the CSE. The OD
values decreased with dilution of the CSE : non-diluted CSE (0.165, 0.166) 1/10 (0.084,
0.086), 1/20 (0.035, 0.038). At the 1/40 and 1/80 dilutions the OD values were not


















Figure 7.8 The binding of monoclonal antibodies to host cell surface antigens on BEC
treated with PBS or water soluble components of cigarette smoke.
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Dilutions
Figure 7.9 OD values for detection of fucose containing components in smoke extract.
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7.4 Discussion
The results of the experiments provided data to answer the question posed in the
introduction. Epidemiological observations found disease or carriage of several
bacterial species was associated with smoking or passive exposure to cigarette smoke.
Cells from smokers bound significantly more of each of the species tested, N.
meningitidis, H. influenzae, M. catarrhalis, N. lactamica, S. pneumoniae, S. aureus, and
B. pertussis. Buccal epithelial cells of non-smokers treated with undiluted CSE
exhibited decreased binding compared to untreated BEC but at dilutions of 1/10 - 1/320
there was increased bacterial binding.
One hypothesis to explain the enhanced bacterial binding to cells of smokers was that
smoking increased expression of some of the host cells antigens used as receptors for
some bacteria. There were no significant differences in binding of monoclonal or
polyclonal antibodies to Lewis antigens, H type 2, fibrinogen or fibronectin to cells of 8
smokers compared with 8 non-smokers. The amount of CD 14 and CD 18 identified as
receptors on HEp-2 cells was too small to analyse on BEC. BEC of non-smokers
treated with CSE at a dilution 1 in 10 exhibited decreased binding of monoclonal
antibodies to Lea, Le^ and Lex compared to untreated BEC. Decreased binding could
be explained if some components of cigarette smoke masked the cell surface antigens
which have been shown to bind some of the bacteria tested e.g, Lea and LeX for S.
aureus and B. pertussis (Saadi et al., 1993; Saadi et al., 1996) The only exception was
increased binding of the monoclonal antibody to H type 2 antigen on the CSE treated
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cells. This might be due to the presence of substances in CSE containing fucose
epitopes that cross-react with H antigen. Binding of the biotinylated Ulex europaeus
lectin to the extract was demonstrated in the spectrophotometric assay, but the material
was not detected at dilutions > 1/40; therefore, other components in the CSE must
contribute to the enhanced bacterial binding.
Exposure to cigarette smoke could contribute to frequency or density of colonisation.
This study indicates there might be increased density of colonisation by several bacterial
species among smokers. In a longitudinal study of bacterial flora of infants, N.
lactamica was isolated more frequently from infants whose mothers smoked
(Mackenzie et al., 1996), and in this study, these bacteria bound in greater numbers to
cells of smokers. Mothers smoking was also associated with isolation of meningococci,
but the numbers of isolates were too small for analysis. No associations between
frequency of isolation and exposure to cigarette smoke were noted for S. aureus, H.
influenzae or S. pneumoniae (Mackenzie et al., 1996). There was, however, a
significant correlation between isolation of each species examined from both mother
and baby.
Shepherd (1992) suggested that a non-smoker who lives with a smoker will be more
likely to develop a respiratory tract infection. As the smoker himself has an increased
risk of disease, this will tend to increase the exposure of the non-smoker to respiratory
pathogens. Chronic exposure of a non-smoker to environmental tobacco smoke is
thought to produce effects similar to those associated with active smoking, for example
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chronic bronchitis (Robbins et al., 1993). In the survey of infants, there was a highly
significant correlation between cotinine levels in respiratory secretions and the number
of cigarettes smoked in the household each day (Mackenzie et al., 1996). If passive
coating of epithelial cells by components of cigarette smoke occurs in vivo as in the
experiments with CSE, it is possible that passive exposure to cigarette smoke could
enhance density of colonisation.
Specific adherence of micro-organisms to epithelial cells is an important step in the
colonisation process. Although non-specific factors such as surface charge, pH, ionic
bridging and hydrophobic interactions might be important (Watt and Ward, 1980), it has
been argued that the attachment of bacteria to host cells is facilitated by specific
interactions. Specific interaction might be necessary since the surface of both host and
bacteria have a net negative charge. This mutual repulsion could be overcome by
interaction of surface molecules which act as ligands (Ofek and Beachey, 1980). The
current study found no difference in expression of specific ligands known to act as
receptors for several bacterial species on cells of smokers and non-smokers: blood group
antigens; fibrinogen; or fibronectin. Enhanced binding noted with dilutions of the CSE
might reflect changes in charge or other non-specific effects on cells.
Although exposure to cigarette smoke enhances susceptibility to respiratory viral
infection, this study indicates that smoking or passive exposure to cigarette smoke alone
can enhance bacterial binding to epithelial cells. Virus infection upregulated expression
of some host cell antigens involved in bacterial binding, but smoking did not. While
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the components in the water soluble extract of cigarette smoke that enhanced bacterial
binding have not been identified, the material cross-reactive with the H antigen might be
one factor. Blood group antigens with an immunodominant fucose have been
demonstrated to be a receptor for at least one bacterial species Helicobacter pylori





This chapter summarises the findings and conclusions with reference to the original
objectives set out in the general introduction, explores the limitations of the
experimental methods of analysis used throughout this study, and makes suggestions for
future work.
8.1 Objectives of the project
Active smoking, passive exposure to cigarette smoke and viral infection are risk factors
for respiratory infection. The general aim of the project was to assess virus infection
and exposure to cigarette smoke for their individual effects on bacterial attachment.
The results of this study provided answers for the questions set at the start of the
investigation. Because the glycoprotein G expressed on RSV-A infected cells was
found to be an additional receptor for meningococci and variations in glycoprotein G
between RSV subgroups A and B had been reported (Akerlind et al., 1988; Anderson et
al., 1991; Cane et al., 1991), the first objective of the study was to determine if there is a
similar pattern of enhanced binding of N. meningitidis, H. influenzae type b, S. aureus,
and B. pertussis to cells infected with RSV subgroup B as observed with RSV subgroup
A. This study showed that HEp-2 cells infected with RSV subgroup B also enhanced
bacterial binding.
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The second aim of the study was to determine if there is increased binding of other
species of bacteria associated with meningitis and those associated with secondary
respiratory infections or exacerbation of chronic bronchitis to RSV-infected cells. For
both RSV A and RSV B infected cells, there was significantly enhanced binding of the
majority of species and strains tested. The only exception was the antibiotic-sensitive
isolates of M. catarrhalis which bound in significantly lower levels to RSV infected
cells. This unusual finding was further explored and significant differences in the OMP
profile and complement sensitivity of antibiotic-sensitive and resistant strains were
found.
The third objective was to test the hypothesis that influenza A virus infection of HEp-2
cells might enhance binding of bacteria associated with meningitis or bacterial species
associated with pneumonia, otitis media and exacerbation of chronic bronchitis. The
results in this study showed that HEp-2 cells infected with human influenza A virus
significantly increased adherence of respiratory tract bacteria tested in the assays. In
contrast to the finding with RSV, the antibiotic-sensitive isolates (MC2-MC8) of M.
catarrhalis also showed significantly increased binding to cells infected with influenza
virus.
The fourth objective was to examine changes in host cell components resulting from
viral infection. As with RSV infection, there was increased binding of monoclonal
antibodies to CD 14 and CD 18 to HEp-2 cells infected with influenza A; but, in contrast
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with RSV infected cells binding of monoclonal antibody to CD 15 was not enhanced.
Neuraminidase treatment also enhanced bacterial binding but not to same extent as
influenza infection, indicating other changes were associated with enhanced binding.
Factors associated with enhanced binding of Gram-negative bacteria (enhanced CD 14
and CD 18) differed from those associated with Gram-positive bacteria (neuraminidase
activity).
The fifth and sixth objectives were to examine the effects of smoking on bacterial
binding, expression of host cell antigens that act as receptors for some species. Cells of
smokers bound more bacteria associated with meningitis or respiratory disease
compared with cells of non-smokers. While cells from smokers bound significantly
greater numbers of all the species tested, there was no difference in level of host cell
antigens which act as receptors for some bacteria on cells of smokers compared with
cells of non-smokers. There appear to be substances in cigarette smoke that enhance
binding of bacteria to epithelial cells (substances similar to H antigen) or perhaps alter
the charges on the cells.
8.2 Applications and limitation of methods and results
8.2.1 Assessment of bacterial binding by flow cytometry
The majority of studies on attachment of bacteria to epithelial cells in vitro have been
carried out by light microscopy (Tramont and Wilson, 1977; Taylor et al., 1990; Riise et
ai, 1994). The basic method consists of mixing epithelial cells with bacteria and
incubating the mixture for an appropriate period. Excess bacteria are removed, the cells
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are resuspended, a drop of suspension dried on a glass slide and examined under the
light microscope.
There are several problems associated with the light microscopy method for assessment
of bacterial binding. Bacteria were not evenly distributed over the BEC. There were
background commensal organisms which affected the counting of bound bacteria and
the number of bacteria observed varied greatly (Andersson et al, 1981). It is a very
laborious method, prone to subjective errors in counting and samples few epithelial
cells. These limitations have been overcome in this study by the use of fluorescein-
labelled bacteria and analysis of the adherence by flow cytometry.
The advantages of flow cytometry are considerable and it provides a powerful tool for
analysing bacterium-cell interactions. It is a reliable and practical method. Large
numbers of cells were analysed in a short period of time. Over a thousand BEC can be
analysed within a few minutes. It is less prone to subjective errors, and, unattached
bacteria are not analysed by the instrument as they are represented in another area of the
bitmap.
8.2.2 The effect of FITC-labelled bacteria on attachment assays
Direct labelling of the bacterial species tested in the study with FITC was the method
chosen for these studies. The FITC does not alter binding to epithelial cells. The
results in the preliminary studies by light microscopy showed there were no differences
between the number of labelled and unlabelled bacteria bound to the cells.
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8.2.3 Detection of host cell surface antigens by flow cytometry
Flow cytometry was used to determine if infection by influenza virus might increase the
expression of host cell surface antigens which can act as receptors for bacteria as
reported for RSV-infected cells (Raza et al., 1994). Influenza virus infected HEp-2
cells showed no changes in expression of Lewis antigens but significantly increased
binding of monoclonal antibodies for the cell surface antigens CD 14 and CD 18
compared to uninfected HEp-2 cells. This might explain how virus infection
contributes to enhanced binding by upregulation of expression of host cell surface
antigens that can act as receptors for Gram-negative bacteria. These results need to be
interpreted with caution. HEp-2 cells are a transformed cell line and could be
expressing more CD14 and CD18 than epithelial cells in vivo as evidenced by the low
levels of anti-CD 14 and anti-CD 18 bound to BEC. While the neuraminidase of
influenza virus might make some epitopes more accessible, it is not the only factor that
contributes to enhanced binding of the bacterial species examined.
8.3 Characteristics of antibiotic-sensitive and antibiotic-resistant M.
catarrhalis isolates
M. catarrhalis is increasingly recognised as an important pathogen in the lower
respiratory tract, producing exacerbation of chronic bronchitis and pneumonia in adults,
especially in patients with compromised respiratory function (Malkamaki et al., 1983).
This study showed that binding of M. catarrhalis to RSV-infected cells was enhanced
for the isolate (MCI) which grew in the presence of the selective antibiotics in NYC
medium. Isolate MC2 and 6 additional antibiotic-sensitive isolates did not grow on the
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selective medium. These were the only exceptions to the pattern of increased binding
observed with RSV-infected HEp-2 cells among all the species tested. The outer
membrane protein profiles of the antibiotic-resistant isolate and the antibiotic-sensitive
isolates differed at three bands. The antibiotic-resistant isolate MCI lacked bands at 81
kDa and 66 kDa which were present in the seven antibiotic-sensitive isolates, while the
antibiotic-resistant isolate had a distinct band at 19 kDa which was not present in the
antibiotic-sensitive isolates.
In the assays for complement-mediated killing, all sera tested had bactericidal activity
against the MC2 isolate but no killing was observed for MCI. While in animal models
the strain expressing the 81 KDa protein was more rapidly cleared from the lungs
(Helminen et al., 1993a), with human monocytes or the THP-1 monocyte cell line
phagocytosis or intracellular survival studies showed no differences between the two
isolates ofM. catarrhalis.
If the 81 kDa protein is associated with both sensitivity to complement killing and
reduced binding to RSV-infected cells, these isolates might be less likely to cause
serious disease following RSV infection. The effects of prolonged use of antibiotics or
selection of strains similar to MCI with characteristics that could contribute to virulence
need to be examined. This might be of particular relevance to children treated for
recurrent otitis media or patients with chronic lung diseases.
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8.4 Smoking and bacterial binding
Cigarette smoking increases the incidence and severity of respiratory infections among
patients with chronic bronchitis and obstructive airways disease. In addition, some
evidence suggests that it directly affects the incidence and severity of respiratory
infections in both healthy smokers and children exposed passively to cigarette smoke.
In addition to physical and physiological damage to mucosa of the respiratory tract, the
results obtained in this study indicate it is an independent factor contributing to density
of colonisation. BEC from smokers attached significantly more of each of the bacteria
species tested. The underlying interactions are not yet clarified, but analysis of
expression of host cell antigens that act as receptors for some species did not differ for
smokers compared with non-smokers.
8.5 Conclusion
Two environmental factors that affect the respiratory tract, viral infection and cigarette
smoke have been associated with susceptibility to invasive bacterial disease. While
both active smoking and passive exposure to cigarette smoke are associated with
increased risk of respiratory virus infection, this study concludes that smoking and viral
infection are two separate risk factors for enhancement of bacterial binding.
8.6 Further studies
1- Additional studies are needed to determine the receptors involved in enhanced
binding of Gram-positive species to RSV or influenza infected HEp-2 cells.
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2- The components of cigarette smoke which enhanced binding of the bacterial species
to epithelial cells from smokers or BEC treated with water soluble components of
cigarette smoke need to be identified. For example, CSE from cigarettes with different
levels of tar might be examined in the model system to assess the effect of these
components on bacterial binding.
3- The results obtained with the two isolates of M. catarrhalis in chapter 5 indicate that
antibiotic usage might contribute to selection of more virulent strains. This hypothesis
could be tested by longitudinal studies of M. catarrhalis from patients with chronic
pulmonary disease on long term antibiotic treatment and studies on mutants of M.
catarrhalis derived from selection by antibiotics commonly used in treatment of
respiratory tract infections. It has been observed that over prescribing of antibiotics
such as erythromycin is more prevalent in area in which there are higher levels of
meningococcal disease. Similar studies on selection and characterisation of
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